Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Scott Lippman

    Address9500 Gilman Drive #0658
    CA La Jolla 92093
    Phone858-822-1222
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Biology of the Prostate Cancer Prevention Trial (PCPT)
      NIH/NCI P01CA108964May 1, 2005 - Apr 30, 2013
      Role: Principal Investigator
      Molecular-Based Therapy for Oral Cancer Prevention
      NIH/NCI P01CA106451Aug 1, 2004 - Jul 31, 2012
      Role: Principal Investigator
      U10 Full Member Application Affiliated with SWOG
      NIH/NCI U10CA105409Jul 26, 2004 - Dec 31, 2015
      Role: Principal Investigator
      Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
      NIH/NCI N01CN35159-8-0-1Sep 30, 2003 - Sep 29, 2012
      Role: Principal Investigator
      Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
      NIH/NCI N01CN35159Sep 30, 2003 - Sep 29, 2008
      Role: Principal Investigator
      M D Anderson Cancer Center Head &Neck SPORE
      NIH/NCI P50CA097007Sep 30, 2002 - Jul 31, 2014
      Role: Principal Investigator
      PHASE III STUDY OF FENRETINIDE IN BLADDER CARCINOFENESIS
      NIH/NCI U01CA077150Sep 30, 1997 - Jul 31, 2004
      Role: Principal Investigator
      BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH &PROGRESSION
      NIH P01CA068233May 6, 1996 - Mar 31, 2005
      Role: Co-Investigator
      PHASE II CLINICAL TRIALS OF NEW CHEMOPRVENTIVE AGENTS
      NIH/NCI N01CN065004Oct 2, 1995 - Jun 30, 2000
      Role: Principal Investigator
      BIOLOGY AND CHEMOPREVENTION OF HEAD AND NECK CANCER
      NIH P01CA052051Aug 5, 1991 - Nov 30, 2004
      Role: Co-Investigator
      Specialized Cancer Center Support Grant
      NIH/NCI P30CA023100Apr 1, 1978 - Apr 30, 2019
      Role: Principal Investigator

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Platz EA, Kulac I, Barber JR, Drake CG, Joshu CE, Nelson WG, Lucia MS, Klein EA, Lippman S, Parnes HL, Thompson IM, Goodman PJ, Tangen CM, De Marzo AM. A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts. Cancer Epidemiol Biomarkers Prev. 2017 Jul 28. PMID: 28754796.
        View in: PubMed
      2. Kato S, Krishnamurthy N, Banks KC, De P, Williams K, Williams C, Leyland-Jones B, Lippman S, Lanman RB, Kurzrock R. Utility of Genomic Analysis In Circulating Tumor DNA from Patients with Carcinoma of Unknown Primary. Cancer Res. 2017 Aug 15; 77(16):4238-4246. PMID: 28642281.
        View in: PubMed
      3. Husain H, Melnikova VO, Kosco K, Woodward B, More S, Pingle SC, Weihe E, Park BH, Tewari M, Erlander MG, Cohen EEW, Lippman S, Kurzrock R. Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clin Cancer Res. 2017 Apr 18. PMID: 28420725.
        View in: PubMed
      4. Spira A, Yurgelun MB, Alexandrov L, Rao A, Bejar R, Polyak K, Giannakis M, Shilatifard A, Finn OJ, Dhodapkar M, Kay NE, Braggio E, Vilar E, Mazzilli SA, Rebbeck TR, Garber JE, Velculescu VE, Disis ML, Wallace DC, Lippman S. Precancer Atlas to Drive Precision Prevention Trials. Cancer Res. 2017 Apr 01; 77(7):1510-1541. PMID: 28373404.
        View in: PubMed
      5. Winchester DA, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Xu J, Zheng SL, Thompson IM, Lucia MS, Lippman S, Parnes HL, Isaacs WB, De Marzo AM, Drake CG, Platz EA. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. Prostate. 2017 Jun; 77(8):908-919. PMID: 28317149.
        View in: PubMed
      6. Carter H, Marty R, Hofree M, Gross A, Jensen J, Fisch KM, Wu X, DeBoever C, Van Nostrand EL, Song Y, Wheeler E, Kreisberg JF, Lippman S, Yeo G, Gutkind S, Ideker T. Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer. Cancer Discov. 2017 Feb 10. PMID: 28188128.
        View in: PubMed
      7. Yurgelun MB, Chenevix-Trench G, Lippman S. Translating Germline Cancer Risk into Precision Prevention. Cell. 2017 Feb 09; 168(4):566-570. PMID: 28187278.
        View in: PubMed
      8. Krishnan AR, Korrapati A, Zou AE, Qu Y, Wang XQ, Califano JA, Wang-Rodriguez J, Lippman S, Hovell MF, Ongkeko WM. Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma. Oral Oncol. 2017 Feb; 65:68-75. PMID: 28109471.
        View in: PubMed
      9. McCaskill-Stevens W, Pearson D, Kramer BS, Ford L, Lippman S. Identifying and Creating the Next Generation of Community-Based Cancer Prevention Studies: Summary of a National Cancer Institute Think Tank. Cancer Prev Res (Phila). 2016 Dec 13. PMID: 27965286.
        View in: PubMed
      10. Wu X, Wen CP, Ye Y, Tsai M, Wen C, Roth JA, Pu X, Chow WH, Huff C, Cunningham S, Huang M, Wu S, Tsao CK, Gu J, Lippman S. Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in Taiwan. Sci Rep. 2016 Nov 02; 6:36482. PMID: 27805040.
        View in: PubMed
      11. Dasanu CA, Lippman S, Plaxe SC. Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer. J Oncol Pharm Pract. 2016 Oct 18. PMID: 27824586.
        View in: PubMed
      12. Adams SR, Yang HC, Savariar EN, Aguilera J, Crisp JL, Jones KA, Whitney MA, Lippman S, Cohen EE, Tsien RY, Advani SJ. Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize. Nat Commun. 2016 Oct 04; 7:13019. PMID: 27698471.
        View in: PubMed
      13. Spira A, Disis ML, Schiller JT, Vilar E, Rebbeck TR, Bejar R, Ideker T, Arts J, Yurgelun MB, Mesirov JP, Rao A, Garber J, Jaffee EM, Lippman S. Leveraging premalignant biology for immune-based cancer prevention. Proc Natl Acad Sci U S A. 2016 Sep 27; 113(39):10750-8. PMID: 27638202.
        View in: PubMed
      14. Owens RL, Gold KA, Gozal D, Peppard PE, Jun JC, Lippman S, Malhotra A. Sleep and Breathing … and Cancer? Cancer Prev Res (Phila). 2016 Nov; 9(11):821-827. PMID: 27604751.
        View in: PubMed
      15. Zou AE, Zheng H, Saad MA, Rahimy M, Ku J, Kuo SZ, Honda TK, Wang-Rodriguez J, Xuan Y, Korrapati A, Yu V, Singh P, Grandis JR, King CC, Lippman S, Wang XQ, Hinton A, Ongkeko WM. The non-coding landscape of head and neck squamous cell carcinoma. Oncotarget. 2016 08 09; 7(32):51211-51222. PMID: 27323410.
        View in: PubMed
      16. Foy JP, Tortereau A, Caulin C, Le Texier V, Lavergne E, Thomas E, Chabaud S, Perol D, Lachuer J, Lang W, Hong WK, Goudot P, Lippman S, Bertolus C, Saintigny P. The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer. Oncotarget. 2016 Jun 14; 7(24):35932-35945. PMID: 27027432.
        View in: PubMed
      17. Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman S, Brown P, Sneige N. Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer. Breast Cancer Res Treat. 2016 Jul; 158(1):67-77. PMID: 27287781.
        View in: PubMed
      18. Kato S, Lippman S, Flaherty KT, Kurzrock R. The Conundrum of Genetic "Drivers" in Benign Conditions. J Natl Cancer Inst. 2016 Aug; 108(8). PMID: 27059373.
        View in: PubMed
      19. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman S, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. PMID: 27322462.
        View in: PubMed
      20. Guertin KA, Grant RK, Arnold KB, Burwell L, Hartline J, Goodman PJ, Minasian LM, Lippman S, Klein E, Cassano PA. Effect of long-term vitamin E and selenium supplementation on urine F2-isoprostanes, a biomarker of oxidative stress. Free Radic Biol Med. 2016 Jun; 95:349-56. PMID: 27012420.
        View in: PubMed
      21. Yamaguchi K, Iglesias-Bartolomé R, Wang Z, Callejas-Valera JL, Amornphimoltham P, Molinolo AA, Cohen EE, Califano JA, Lippman S, Luo J, Gutkind JS. A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers. Oncotarget. 2016 Mar 8; 7(10):10696-709. PMID: 26882569.
        View in: PubMed
      22. Schwaederle M, Parker BA, Schwab RB, Daniels GA, Piccioni DE, Kesari S, Helsten TL, Bazhenova LA, Romero J, Fanta PT, Lippman S, Kurzrock R. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Mol Cancer Ther. 2016 Apr; 15(4):743-52. PMID: 26873727.
        View in: PubMed
      23. William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman S. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb 1; 2(2):209-16. PMID: 26540028.
        View in: PubMed
      24. Winchester DA, Gurel B, Till C, Goodman PJ, Tangen CM, Santella RM, Johnson-Pais TL, Leach RJ, Thompson IM, Xu J, Zheng SL, Lucia MS, Lippman S, Parnes HL, Isaacs WB, Drake CG, De Marzo AM, Platz EA. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial. Prostate. 2016 May; 76(6):565-74. PMID: 26771888.
        View in: PubMed
      25. Kensler TW, Spira A, Garber JE, Szabo E, Lee JJ, Dong Z, Dannenberg AJ, Hait WN, Blackburn E, Davidson NE, Foti M, Lippman S. Transforming Cancer Prevention through Precision Medicine and Immune-oncology. Cancer Prev Res (Phila). 2016 Jan; 9(1):2-10. PMID: 26744449.
        View in: PubMed
      26. Lippman S. Catalyzing Cancer Prevention Research CaPR: A New Year/New Opportunities. Cancer Prev Res (Phila). 2016 Jan; 9(1):1. PMID: 26744448.
        View in: PubMed
      27. Murtola TJ, Gurel B, Umbehr M, Lucia MS, Thompson IM, Goodman PJ, Kristal AR, Parnes HL, Lippman S, Sutcliffe S, Peskoe SB, Barber JR, Drake CG, Nelson WG, De Marzo AM, Platz EA. Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2016 Mar; 25(3):463-9. PMID: 26715424.
        View in: PubMed
      28. Meyskens FL, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman S, Alberts DS. Cancer Prevention: Obstacles, Challenges and the Road Ahead. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26547931.
        View in: PubMed
      29. Patel SP, Schwaederle M, Daniels GA, Fanta PT, Schwab RB, Shimabukuro KA, Kesari S, Piccioni DE, Bazhenova LA, Helsten TL, Lippman S, Parker BA, Kurzrock R. Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. Oncotarget. 2015 Oct 20; 6(32):32602-9. PMID: 26418953.
        View in: PubMed
      30. Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman S, Perloff M, Brown PH, Lightdale CJ. Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prev Res (Phila). 2015 Dec; 8(12):1131-7. PMID: 26471236.
        View in: PubMed
      31. Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Frederick MJ, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar AK, Lee JJ, Myers JN, Issa JP, Lippman S, Mao L, Saintigny P. New DNA Methylation Markers and Global DNA Hypomethylation Are Associated with Oral Cancer Development. Cancer Prev Res (Phila). 2015 Nov; 8(11):1027-35. PMID: 26342026.
        View in: PubMed
      32. Maresso KC, Tsai KY, Brown PH, Szabo E, Lippman S, Hawk ET. Molecular cancer prevention: Current status and future directions. CA Cancer J Clin. 2015 Sep; 65(5):345-83. PMID: 26284997.
        View in: PubMed
      33. Nash SH, Till C, Song X, Lucia MS, Parnes HL, Thompson IM, Lippman S, Platz EA, Schenk J. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1507-15. PMID: 26269564.
        View in: PubMed
      34. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman S, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600.
        View in: PubMed
      35. Kim JS, Kim ES, Liu D, Lee JJ, Behrens C, Lippman S, Hong WK, Wistuba II, Lee E, Lee HY. Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer. Oncotarget. 2015 Jun 30; 6(18):16746-56. PMID: 25944691.
        View in: PubMed
      36. Krogan NJ, Lippman S, Agard DA, Ashworth A, Ideker T. The Cancer Cell Map Initiative: Defining the Hallmark Networks of Cancer. Mol Cell. 2015 May 21; 58(4):690-698. PMID: 26000852.
        View in: PubMed
      37. Umbehr MH, Gurel B, Murtola TJ, Sutcliffe S, Peskoe SB, Tangen CM, Goodman PJ, Thompson IM, Lippman S, Lucia MS, Parnes HL, Drake CG, Nelson WG, De Marzo AM, Platz EA. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4?ng?ml(-1), normal DRE and negative for prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):264-9. PMID: 25939516.
        View in: PubMed
      38. Nash SH, Schenk JM, Kristal AR, Goodman PJ, Lucia MS, Parnes HL, Thompson IM, Lippman S, Song X, Gurel B, De Marzo A, Platz EA. Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila). 2015 Jul; 8(7):590-6. PMID: 25926387.
        View in: PubMed
      39. Heaphy CM, Gaonkar G, Peskoe SB, Joshu CE, De Marzo AM, Lucia MS, Goodman PJ, Lippman S, Thompson IM, Platz EA, Meeker AK. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate. 2015 Aug; 75(11):1160-6. PMID: 25893825.
        View in: PubMed
      40. Cassano PA, Guertin KA, Kristal AR, Ritchie KE, Bertoia ML, Arnold KB, Crowley JJ, Hartline J, Goodman PJ, Tangen CM, Minasian LM, Lippman S, Klein E. A randomized controlled trial of vitamin E and selenium on rate of decline in lung function. Respir Res. 2015; 16(1):35. PMID: 25889509.
        View in: PubMed
      41. Hoque A, Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, vanBokhoven A, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman S, Ambrosone CB, Thompson IM. Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease. Urology. 2015 Mar; 85(3):616-20. PMID: 25733274.
        View in: PubMed
      42. Raju SC, Hauff SJ, Lemieux AJ, Orosco RK, Gross AM, Nguyen LT, Savariar E, Moss W, Whitney M, Cohen EE, Lippman S, Tsien RY, Ideker T, Advani SJ, Nguyen QT. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma. Oral Oncol. 2015 May; 51(5):470-5. PMID: 25735654.
        View in: PubMed
      43. Kim ES, Ye Y, Vaporciyan AA, Xing J, Huang M, Gu J, Roth JA, Lippman S, Wu X. Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study. J Thorac Oncol. 2015 Feb; 10(2):302-8. PMID: 25299235.
        View in: PubMed
      44. Christen WG, Glynn RJ, Gaziano JM, Darke AK, Crowley JJ, Goodman PJ, Lippman S, Lad TE, Bearden JD, Goodman GE, Minasian LM, Thompson IM, Blanke CD, Klein EA. Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial. JAMA Ophthalmol. 2015 Jan 1; 133(1):17-24. PMID: 25232809.
        View in: PubMed
      45. Wen CP, Zhang F, Liang D, Wen C, Gu J, Skinner H, Chow WH, Ye Y, Pu X, Hildebrandt MA, Huang M, Chen CH, Hsiung CA, Tsai MK, Tsao CK, Lippman S, Wu X. The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clin Cancer Res. 2015 Jan 1; 21(1):193-200. PMID: 25336700.
        View in: PubMed
      46. Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman S, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications. Clin Cancer Res. 2014 Dec 15; 20(24):6570-81. PMID: 25316813.
        View in: PubMed
      47. Jones RL, Kim ES, Nava-Parada P, Alam S, Johnson FM, Stephens AW, Simantov R, Poondru S, Gedrich R, Lippman S, Kaye SB, Carden CP. Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors. Clin Cancer Res. 2015 Feb 15; 21(4):693-700. PMID: 25208878.
        View in: PubMed
      48. Hauff SJ, Raju SC, Orosco RK, Gross AM, Diaz-Perez JA, Savariar E, Nashi N, Hasselman J, Whitney M, Myers JN, Lippman S, Tsien RY, Ideker T, Nguyen QT. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):612-8. PMID: 25091190.
        View in: PubMed
      49. Gross AM, Orosco RK, Shen JP, Egloff AM, Carter H, Hofree M, Choueiri M, Coffey CS, Lippman S, Hayes DN, Cohen EE, Grandis JR, Nguyen QT, Ideker T. Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss. Nat Genet. 2014 Sep; 46(9):939-43. PMID: 25086664.
        View in: PubMed
      50. Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman S, Kurzrock R. Molecular tumor board: the university of california san diego moores cancer center experience. Oncologist. 2014 Jun; 19(6):631-6. PMID: 24797821.
        View in: PubMed
      51. Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, Lippman S, Desgrosellier JS, Anand S, Weis SM, Cheresh DA. An integrin ß3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nat Cell Biol. 2014 May; 16(5):457-68. PMID: 24747441.
        View in: PubMed
      52. Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman S, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):847-56. PMID: 24748218.
        View in: PubMed
      53. He Y, Gong Y, Gu J, Lee JJ, Lippman S, Wu X. Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study. Carcinogenesis. 2014 Aug; 35(8):1760-4. PMID: 24743515.
        View in: PubMed
      54. Greenwald P, Stoner G, Colburn N, Lippman S. John a. Milner: in memoriam (1947-2013). Cancer Prev Res (Phila). 2014 Apr; 7(4):373-4. PMID: 24695271.
        View in: PubMed
      55. Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman S, Hershman DL. Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. J Hum Nutr Diet. 2015 Jun; 28(3):272-82. PMID: 24646362.
        View in: PubMed
      56. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL, Goodman GE, Minasian LM, Parnes HL, Lippman S, Klein EA. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar 1; 106(3):djt456. PMID: 24563519.
        View in: PubMed
      57. Lippman S. Letter from the Editor. Cancer Prev Res (Phila). 2014 Feb; 7(2):179-81. PMID: 24464731.
        View in: PubMed
      58. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman S, Hong WK, Wistuba II, Lee HY. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer. Clin Lung Cancer. 2014 May; 15(3):213-21. PMID: 24485233.
        View in: PubMed
      59. Blumenschein GR, Saintigny P, Liu S, Kim ES, Tsao AS, Herbst RS, Alden C, Lee JJ, Tang X, Stewart DJ, Kies MS, Fossella FV, Tran HT, Mao L, Hicks ME, Erasmus J, Gupta S, Girard L, Peyton M, Diao L, Wang J, Davis SE, Minna JD, Wistuba I, Hong WK, Heymach JV, Lippman S. Comprehensive Biomarker Analysis and Final Efficacy Results of Sorafenib in the BATTLE Trial. Clin Cancer Res. 2013 Dec 15; 19(24):6967-75. PMID: 24166906.
        View in: PubMed
      60. Falchook GS, Lippman S, Bastida CC, Kurzrock R. Human epidermal receptor 2-amplified salivary duct carcinoma: Regression with dual human epidermal receptor 2 inhibition and anti-vascular endothelial growth factor combination treatment. Head Neck. 2014 Mar; 36(3):E25-7. PMID: 23852769.
        View in: PubMed
      61. Shin DH, Lee HJ, Min HY, Choi SP, Lee MS, Lee JW, Johnson FM, Mehta K, Lippman S, Glisson BS, Lee HY. Combating resistance to anti-IGFR antibody by targeting the integrin ß3-Src pathway. J Natl Cancer Inst. 2013 Oct 16; 105(20):1558-70. PMID: 24092920.
        View in: PubMed
      62. Bau DT, Lippman S, Xu E, Gong Y, Lee JJ, Wu X, Gu J. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer. 2013 Dec 15; 119(24):4277-83. PMID: 24105340.
        View in: PubMed
      63. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippman S, Ruckdeschel J, Khuri FR. Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer: ECOG 5597. J Clin Oncol. 2013 Nov 20; 31(33):4179-87. PMID: 24002495.
        View in: PubMed
      64. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, Runowicz C, Vogel VG, Wade JL, Lippman S. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2013 Aug 10; 31(23):2942-62. PMID: 23835710.
        View in: PubMed
      65. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman S, El-Naggar AK. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013; 8(6):e66778. PMID: 23825564.
        View in: PubMed
      66. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman S, Ye Y, Minna JD, Wu X. Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer. Cancer Res. 2013 Aug 1; 73(15):4801-9. PMID: 23774211.
        View in: PubMed
      67. Stephens PJ, Davies HR, Mitani Y, Van Loo P, Shlien A, Tarpey PS, Papaemmanuil E, Cheverton A, Bignell GR, Butler AP, Gamble J, Gamble S, Hardy C, Hinton J, Jia M, Jayakumar A, Jones D, Latimer C, McLaren S, McBride DJ, Menzies A, Mudie L, Maddison M, Raine K, Nik-Zainal S, O'Meara S, Teague JW, Varela I, Wedge DC, Whitmore I, Lippman S, McDermott U, Stratton MR, Campbell PJ, El-Naggar AK, Futreal PA. Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest. 2013 Jul 1; 123(7):2965-8. PMID: 23778141.
        View in: PubMed
      68. Wu X, Wang L, Ye Y, Aakre JA, Pu X, Chang GC, Yang PC, Roth JA, Marks RS, Lippman S, Chang JY, Lu C, Deschamps C, Su WC, Wang WC, Huang MS, Chang DW, Li Y, Pankratz VS, Minna JD, Hong WK, Hildebrandt MA, Hsiung CA, Yang P. Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers. Cancer Res. 2013 Jul 1; 73(13):4028-38. PMID: 23704207.
        View in: PubMed
      69. Tsao AS, Liu S, Lee JJ, Alden CM, Blumenschein GR, Herbst R, Davis SE, Kim E, Lippman S, Heymach J, Tran H, Tang X, Wistuba I, Hong WK. Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trial. J Thorac Oncol. 2013 May; 8(5):658-61. PMID: 23584298.
        View in: PubMed
      70. Zhang L, Mitani Y, Caulin C, Rao PH, Kies MS, Saintigny P, Zhang N, Weber RS, Lippman S, El-Naggar AK. Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance. Am J Pathol. 2013 Jun; 182(6):2048-57. PMID: 23583282.
        View in: PubMed
      71. Tam AL, Kim ES, Lee JJ, Ensor JE, Hicks ME, Tang X, Blumenschein GR, Alden CM, Erasmus JJ, Tsao A, Lippman S, Hong WK, Wistuba II, Gupta S. Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol. 2013 Apr; 8(4):436-42. PMID: 23442309.
        View in: PubMed
      72. Pu X, Roth JA, Hildebrandt MA, Ye Y, Wei H, Minna JD, Lippman S, Wu X. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients. Cancer Res. 2013 Mar 15; 73(6):1867-75. PMID: 23378343.
        View in: PubMed
      73. Lippman S. Looking forward to 2013--saluting the exceptional year in 2012. Cancer Prev Res (Phila). 2013 Jan; 6(1):1-3. PMID: 23282630.
        View in: PubMed
      74. Wang JL, Gold KA, Lippman S. Natural-agent mechanisms and early-phase clinical development. Top Curr Chem. 2013; 329:241-52. PMID: 22851156.
        View in: PubMed
      75. Yan W, Shih J, Rodriguez-Canales J, Tangrea MA, Player A, Diao L, Hu N, Goldstein AM, Wang J, Taylor PR, Lippman S, Wistuba II, Emmert-Buck MR, Erickson HS. Three-dimensional mRNA measurements reveal minimal regional heterogeneity in esophageal squamous cell carcinoma. Am J Pathol. 2013 Feb; 182(2):529-39. PMID: 23219752.
        View in: PubMed
      76. El-Sawy T, Sabichi AL, Myers JN, Kies MS, William WN, Glisson BS, Lippman S, Esmaeli B. Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma. Arch Ophthalmol. 2012 Dec; 130(12):1608-11. PMID: 23229707.
        View in: PubMed
      77. Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, Kim ES, Herbst RS, Lippman S, Wistuba II, Hong WK, Kurie JM, Koo JS. CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma. Cancer Res. 2013 Jan 15; 73(2):571-82. PMID: 23204236.
        View in: PubMed
      78. Tsao AS, Liu S, Lee JJ, Alden C, Blumenschein G, Herbst R, Davis SE, Kim E, Lippman S, Stewart D, Tang XM, Wistuba I, Hong WK. Clinical outcomes and biomarker profiles of elderly pretreated NSCLC patients from the BATTLE trial. J Thorac Oncol. 2012 Nov; 7(11):1645-52. PMID: 23059780.
        View in: PubMed
      79. Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Tumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJ, Bearss DJ, Warner SL, Foulks JM, Kanner SB, Gandhi V, Krett N, Rosen ST, Kim ES, Herbst RS, Blumenschein GR, Lee JJ, Lippman S, Ang KK, Mills GB, Hong WK, Weinstein JN, Wistuba II, Coombes KR, Minna JD, Heymach JV. An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res. 2013 Jan 1; 19(1):279-90. PMID: 23091115.
        View in: PubMed
      80. Pu X, Ye Y, Spitz MR, Wang L, Gu J, Lippman S, Hildebrandt MA, Hong WK, Minna JD, Roth JA, Yang P, Wu X. Predictors of survival in never-smokers with non-small cell lung cancer: a large-scale, two-phase genetic study. Clin Cancer Res. 2012 Nov 1; 18(21):5983-91. PMID: 22977190.
        View in: PubMed
      81. Byers LA, Wang J, Nilsson MB, Fujimoto J, Saintigny P, Yordy J, Giri U, Peyton M, Fan YH, Diao L, Masrorpour F, Shen L, Liu W, Duchemann B, Tumula P, Bhardwaj V, Welsh J, Weber S, Glisson BS, Kalhor N, Wistuba II, Girard L, Lippman S, Mills GB, Coombes KR, Weinstein JN, Minna JD, Heymach JV. Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1. Cancer Discov. 2012 Sep; 2(9):798-811. PMID: 22961666.
        View in: PubMed
      82. Kristal AR, Till C, Tangen CM, Goodman PJ, Neuhouser ML, Stanczyk FZ, Chu LW, Patel SK, Thompson IM, Reichardt JK, Hoque A, Platz EA, Figg WD, Van Bokhoven A, Lippman S, Hsing AW. Associations of serum sex steroid hormone and 5a-androstane-3a,17ß-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1823-32. PMID: 22879203.
        View in: PubMed
      83. Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C, McArthur HL, Chang J, Rimawi M, Vornik L, Cornelison TL, Wang A, Hibshoosh H, Ahmed A, Terry MB, Santella RM, Lippman S, Hershman DL. Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila). 2012 Sep; 5(9):1144-54. PMID: 22827973.
        View in: PubMed
      84. Saintigny P, Peng S, Zhang L, Sen B, Wistuba II, Lippman S, Girard L, Minna JD, Heymach JV, Johnson FM. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol Cancer Ther. 2012 Sep; 11(9):2021-32. PMID: 22807579.
        View in: PubMed
      85. Lin J, Lu C, Stewart DJ, Gu J, Huang M, Chang DW, Lippman S, Wu X. Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk. Carcinogenesis. 2012 Sep; 33(9):1699-706. PMID: 22665367.
        View in: PubMed
      86. Hildebrandt MA, Lippman S, Etzel CJ, Kim E, Lee JJ, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention. Clin Cancer Res. 2012 Jul 1; 18(13):3705-13. PMID: 22577058.
        View in: PubMed
      87. Kim WY, Prudkin L, Feng L, Kim ES, Hennessy B, Lee JS, Lee JJ, Glisson B, Lippman S, Wistuba II, Hong WK, Lee HY. Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors. Cancer. 2012 Aug 15; 118(16):3993-4003. PMID: 22359227.
        View in: PubMed
      88. Ihle NT, Byers LA, Kim ES, Saintigny P, Lee JJ, Blumenschein GR, Tsao A, Liu S, Larsen JE, Wang J, Diao L, Coombes KR, Chen L, Zhang S, Abdelmelek MF, Tang X, Papadimitrakopoulou V, Minna JD, Lippman S, Hong WK, Herbst RS, Wistuba II, Heymach JV, Powis G. Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome. J Natl Cancer Inst. 2012 Feb 8; 104(3):228-39. PMID: 22247021.
        View in: PubMed
      89. Santarpia L, Lippman S, El-Naggar AK. Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012 Jan; 16(1):103-19. PMID: 22239440.
        View in: PubMed
      90. Lippman S. Letter from the editor. Cancer Prev Res (Phila). 2012 Jan; 5(1):1-2. PMID: 22219161.
        View in: PubMed
      91. Wu X, Lippman S. An intermittent approach for cancer chemoprevention. Nat Rev Cancer. 2011 Dec; 11(12):879-85. PMID: 22071977.
        View in: PubMed
      92. Chan AT, Lippman S. Aspirin and colorectal cancer prevention in Lynch syndrome. Lancet. 2011 Dec 17; 378(9809):2051-2. PMID: 22036018.
        View in: PubMed
      93. Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman S, Goodman GE, Meyskens FL, Baker LH. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306(14):1549-56. PMID: 21990298.
        View in: PubMed
      94. Shin DH, Min HY, El-Naggar AK, Lippman S, Glisson B, Lee HY. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48. PMID: 21980128.
        View in: PubMed
      95. Mitani Y, Rao PH, Futreal PA, Roberts DB, Stephens PJ, Zhao YJ, Zhang L, Mitani M, Weber RS, Lippman S, Caulin C, El-Naggar AK. Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome. Clin Cancer Res. 2011 Nov 15; 17(22):7003-14. PMID: 21976542.
        View in: PubMed
      96. Yin J, Lu C, Gu J, Lippman S, Hildebrandt MA, Lin J, Stewart D, Spitz MR, Wu X. Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancer. Carcinogenesis. 2011 Dec; 32(12):1867-71. PMID: 21965272.
        View in: PubMed
      97. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman S, Hong WK, Wistuba II, Lee HY. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer. 2012 May 1; 118(9):2454-65. PMID: 21952750.
        View in: PubMed
      98. Marshall JR, Tangen CM, Sakr WA, Wood DP, Berry DL, Klein EA, Lippman S, Parnes HL, Alberts DS, Jarrard DF, Lee WR, Gaziano JM, Crawford ED, Ely B, Ray M, Davis W, Minasian LM, Thompson IM. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. Cancer Prev Res (Phila). 2011 Nov; 4(11):1761-9. PMID: 21896650.
        View in: PubMed
      99. Tang L, Yao S, Till C, Goodman PJ, Tangen CM, Wu Y, Kristal AR, Platz EA, Neuhouser ML, Stanczyk FZ, Reichardt JK, Santella RM, Hsing A, Hoque A, Lippman S, Thompson IM, Ambrosone CB. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis. 2011 Oct; 32(10):1500-6. PMID: 21771722.
        View in: PubMed
      100. Yao S, Till C, Kristal AR, Goodman PJ, Hsing AW, Tangen CM, Platz EA, Stanczyk FZ, Reichardt JK, Tang L, Neuhouser ML, Santella RM, Figg WD, Price DK, Parnes HL, Lippman S, Thompson IM, Ambrosone CB, Hoque A. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. Cancer Causes Control. 2011 Aug; 22(8):1121-31. PMID: 21667068.
        View in: PubMed
      101. Kim ES, Herbst RS, Wistuba II, Lee JJ, Blumenschein GR, Tsao A, Stewart DJ, Hicks ME, Erasmus J, Gupta S, Alden CM, Liu S, Tang X, Khuri FR, Tran HT, Johnson BE, Heymach JV, Mao L, Fossella F, Kies MS, Papadimitrakopoulou V, Davis SE, Lippman S, Hong WK. The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov. 2011 Jun; 1(1):44-53. PMID: 22586319.
        View in: PubMed
      102. Kim JH, Choi DS, Lee OH, Oh SH, Lippman S, Lee HY. Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events. Blood. 2011 Sep 1; 118(9):2622-31. PMID: 21551235.
        View in: PubMed
      103. Lin M, Stewart DJ, Spitz MR, Hildebrandt MA, Lu C, Lin J, Gu J, Huang M, Lippman S, Wu X. Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer. Carcinogenesis. 2011 Jul; 32(7):1050-6. PMID: 21515830.
        View in: PubMed
      104. Wu X, Ye Y, Rosell R, Amos CI, Stewart DJ, Hildebrandt MA, Roth JA, Minna JD, Gu J, Lin J, Buch SC, Nukui T, Ramirez Serrano JL, Taron M, Cassidy A, Lu C, Chang JY, Lippman S, Hong WK, Spitz MR, Romkes M, Yang P. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy. J Natl Cancer Inst. 2011 May 18; 103(10):817-25. PMID: 21483023.
        View in: PubMed
      105. William WN, Kim JS, Liu DD, Solis L, Behrens C, Lee JJ, Lippman S, Kim ES, Hong WK, Wistuba II, Lee HY. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol. 2012 Jan; 23(1):78-85. PMID: 21430184.
        View in: PubMed
      106. Veronesi G, Szabo E, Decensi A, Guerrieri-Gonzaga A, Bellomi M, Radice D, Ferretti S, Pelosi G, Lazzeroni M, Serrano D, Lippman S, Spaggiari L, Nardi-Pantoli A, Harari S, Varricchio C, Bonanni B. Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules. Cancer Prev Res (Phila). 2011 Jan; 4(1):34-42. PMID: 21163939.
        View in: PubMed
      107. Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman S. Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. Cancer Prev Res (Phila). 2010 Dec; 3(12):1523-33. PMID: 21149329.
        View in: PubMed
      108. Johnson FM, Bekele BN, Feng L, Wistuba I, Tang XM, Tran HT, Erasmus JJ, Hwang LL, Takebe N, Blumenschein GR, Lippman S, Stewart DJ. Phase II study of dasatinib in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010 Oct 20; 28(30):4609-15. PMID: 20855820.
        View in: PubMed
      109. Zhang X, Yang H, Lee JJ, Kim E, Lippman S, Khuri FR, Spitz MR, Lotan R, Hong WK, Wu X. MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010 Dec; 31(12):2118-23. PMID: 20819778.
        View in: PubMed
      110. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman S, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One. 2010; 5(8):e12402. PMID: 20811626.
        View in: PubMed
      111. Lazzeroni M, Guerrieri-Gonzaga A, Serrano D, Varricchio MC, Veronesi G, Radice D, Feroce I, Nardi-Pantoli A, Lippman S, Szabo E, Bonanni B. Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology. Contemp Clin Trials. 2010 Nov; 31(6):612-9. PMID: 20719253.
        View in: PubMed
      112. Mitani Y, Li J, Rao PH, Zhao YJ, Bell D, Lippman S, Weber RS, Caulin C, El-Naggar AK. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010 Oct 1; 16(19):4722-31. PMID: 20702610.
        View in: PubMed
      113. Wang J, Lippman S, Lee JJ, Yang H, Khuri FR, Kim E, Lin J, Chang DW, Lotan R, Hong WK, Wu X. Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma. Carcinogenesis. 2010 Oct; 31(10):1755-61. PMID: 20627871.
        View in: PubMed
      114. Moinpour CM, Vaught NL, Goldman B, Redman MW, Philip PA, Millwood B, Lippman S, Seay TE, Flynn PJ, O'Reilly EM, Rowland KM, Wong RP, Benedetti J, Blanke CD. Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. J Clin Oncol. 2010 Aug 1; 28(22):3611-6. PMID: 20606094.
        View in: PubMed
      115. Jacoby JJ, Erez B, Korshunova MV, Williams RR, Furutani K, Takahashi O, Kirkpatrick L, Lippman S, Powis G, O'Reilly MS, Herbst RS. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice. J Thorac Oncol. 2010 Jul; 5(7):940-9. PMID: 20512076.
        View in: PubMed
      116. Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman S, Tsao AS. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010; 2:15. PMID: 20587061.
        View in: PubMed
      117. Shureiqi I, Chen D, Day RS, Zuo X, Hochman FL, Ross WA, Cole RA, Moy O, Morris JS, Xiao L, Newman RA, Yang P, Lippman S. Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38. PMID: 20570882.
        View in: PubMed
      118. Byers LA, Holsinger FC, Kies MS, William WN, El-Naggar AK, Lee JJ, Hu J, Lopez A, Tran HT, Yan S, Du Z, Ang KK, Glisson BS, Raso MG, Wistuba II, Myers JN, Hong WK, Papadimitrakopoulou V, Lippman S, Heymach JV. Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. Mol Cancer Ther. 2010 Jun; 9(6):1755-63. PMID: 20530716.
        View in: PubMed
      119. Lee JJ, Feng L, Reshef DS, Sabichi AL, Williams B, Rinsurongkawong W, Wistuba II, Lotan R, Lippman S. Mortality in the randomized, controlled lung intergroup trial of isotretinoin. Cancer Prev Res (Phila). 2010 Jun; 3(6):738-44. PMID: 20501862.
        View in: PubMed
      120. William WN, Kies MS, Fossella FV, Liu DD, Gladish G, Tse WH, Lee JJ, Hong WK, Lippman S, Kim ES. Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer. Cancer. 2010 May 15; 116(10):2401-8. PMID: 20225327.
        View in: PubMed
      121. William WN, Khuri FR, Fossella FV, Glisson BS, Zinner RG, Lee JJ, Herbst RS, Lippman S, Kim ES. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy. Am J Clin Oncol. 2010 Apr; 33(2):148-52. PMID: 19687727.
        View in: PubMed
      122. Blackburn EH, Tlsty TD, Lippman S. Unprecedented opportunities and promise for cancer prevention research. Cancer Prev Res (Phila). 2010 Apr; 3(4):394-402. PMID: 20354163.
        View in: PubMed
      123. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman S, Schwartz DL. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 1; 78(3):667-74. PMID: 20171802.
        View in: PubMed
      124. Clague J, Lippman S, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010 Feb; 49(2):183-9. PMID: 19851984.
        View in: PubMed
      125. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, Guo Z, Qiao Y, Gillenwater AM, Myers JN, Clayman GL, Weber RS, El-Naggar AK, Mao L, Lippman S, Hong WK, Wei Q. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res. 2010 Jan 15; 16(2):764-74. PMID: 20068090.
        View in: PubMed
      126. Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, Reichardt JK. Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat. 2010 Jan; 31(1):67-73. PMID: 19877174.
        View in: PubMed
      127. Kies MS, Holsinger FC, Lee JJ, William WN, Glisson BS, Lin HY, Lewin JS, Ginsberg LE, Gillaspy KA, Massarelli E, Byers L, Lippman S, Hong WK, El-Naggar AK, Garden AS, Papadimitrakopoulou V. Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 1; 28(1):8-14. PMID: 19917840.
        View in: PubMed
      128. Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman S, Dannenberg AJ. Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila). 2009 Nov; 2(11):957-65. PMID: 19843689.
        View in: PubMed
      129. Visvanathan K, Lippman S, Hurley P, Temin S. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Gynecol Oncol. 2009 Oct; 115(1):132-4. PMID: 19716939.
        View in: PubMed
      130. Saintigny P, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim ES, Hong WK, Lippman S, Mao L. DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia. Clin Cancer Res. 2009 Oct 1; 15(19):6284-91. PMID: 19773378.
        View in: PubMed
      131. Kim WY, Jin Q, Oh SH, Kim ES, Yang YJ, Lee DH, Feng L, Behrens C, Prudkin L, Miller YE, Lee JJ, Lippman S, Hong WK, Wistuba II, Lee HY. Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development. Cancer Res. 2009 Sep 15; 69(18):7439-48. PMID: 19738076.
        View in: PubMed
      132. Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman S, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M. Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology. 2009; 77(2):75-81. PMID: 19571599.
        View in: PubMed
      133. Wu X, Spitz MR, Lee JJ, Lippman S, Ye Y, Yang H, Khuri FR, Kim E, Gu J, Lotan R, Hong WK. Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants. Cancer Prev Res (Phila). 2009 Jul; 2(7):617-24. PMID: 19584075.
        View in: PubMed
      134. Platz EA, Lippman S. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial. J Clin Oncol. 2009 Aug 1; 27(22):3569-72. PMID: 19528369.
        View in: PubMed
      135. Lippman S, Hawk ET. Cancer prevention: from 1727 to milestones of the past 100 years. Cancer Res. 2009 Jul 1; 69(13):5269-84. PMID: 19491253.
        View in: PubMed
      136. Lippman S. Cancer prevention research: back to the future. Cancer Prev Res (Phila). 2009 Jun; 2(6):503-13. PMID: 19491288.
        View in: PubMed
      137. Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, Cuzick J, Kramer BS, Lippman S. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009 Jul 1; 27(19):3235-58. PMID: 19470930.
        View in: PubMed
      138. Craft BS, Kurzrock R, Lei X, Herbst R, Lippman S, Fu S, Karp DD. The changing face of phase 1 cancer clinical trials: new challenges in study requirements. Cancer. 2009 Apr 15; 115(8):1592-7. PMID: 19165808.
        View in: PubMed
      139. Pu X, Lippman S, Yang H, Lee JJ, Wu X. Cyclooxygenase-2 gene polymorphisms reduce the risk of oral premalignant lesions. Cancer. 2009 Apr 1; 115(7):1498-506. PMID: 19197984.
        View in: PubMed
      140. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman S, Schwartz DL. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol. 2009 May 20; 27(15):2509-15. PMID: 19332725.
        View in: PubMed
      141. William WN, Lin HY, Lee JJ, Lippman S, Roth JA, Kim ES. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data. Chest. 2009 Sep; 136(3):701-9. PMID: 19318668.
        View in: PubMed
      142. Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman S, Miller JH. Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells. Mol Cancer Ther. 2009 Mar; 8(3):521-32. PMID: 19276160.
        View in: PubMed
      143. Kristal AR, Lippman S. Nutritional prevention of cancer: new directions for an increasingly complex challenge. J Natl Cancer Inst. 2009 Mar 18; 101(6):363-5. PMID: 19276449.
        View in: PubMed
      144. William WN, Heymach JV, Kim ES, Lippman S. Molecular targets for cancer chemoprevention. Nat Rev Drug Discov. 2009 Mar; 8(3):213-25. PMID: 19247304.
        View in: PubMed
      145. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman S, Logothetis CJ, Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4; 101(5):306-20. PMID: 19244175.
        View in: PubMed
      146. William WN, Lee JL, Shin DM, Hong WK, Liu S, Lee JJ, Lippman S, Khuri FR, Kim ES. Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors. Am J Clin Oncol. 2009 Feb; 32(1):15-9. PMID: 19194117.
        View in: PubMed
      147. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, William WN, Atwell A, Lee JJ, Gillenwater A, El-Naggar A, Wu X, Lippman S, Hittelman WN, Hong WK. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21. PMID: 19139013.
        View in: PubMed
      148. William WN, Lee JJ, Lippman S, Martin JW, Chakravarti N, Tran HT, Sabichi AL, Kim ES, Feng L, Lotan R, Papadimitrakopoulou VA. High-dose fenretinide in oral leukoplakia. Cancer Prev Res (Phila). 2009 Jan; 2(1):22-6. PMID: 19139014.
        View in: PubMed
      149. Lippman S. Cancer Prevention Research. Letter from the Editor. Cancer Prev Res (Phila). 2009 Jan; 2(1):1-2. PMID: 19139009.
        View in: PubMed
      150. Papadimitrakopoulou VA, Lee JJ, William WN, Martin JW, Thomas M, Kim ES, Khuri FR, Shin DM, Feng L, Hong WK, Lippman S. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy. J Clin Oncol. 2009 Feb 1; 27(4):599-604. PMID: 19075276.
        View in: PubMed
      151. Lippman S, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL, Baker LH, Coltman CA. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 7; 301(1):39-51. PMID: 19066370.
        View in: PubMed
      152. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 2008 Dec; 134(6):1349; author reply 1350. PMID: 19059972.
        View in: PubMed
      153. Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL, Li LY, Watkins CL, Sellers MV, Lowe ES, Sun Y, Liao ML, Osterlind K, Reck M, Armour AA, Shepherd FA, Lippman S, Douillard JY. Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial. Lancet. 2008 Nov 22; 372(9652):1809-18. PMID: 19027483.
        View in: PubMed
      154. Lippman S. The future of molecular-targeted cancer chemoprevention. Gastroenterology. 2008 Dec; 135(6):1834-41. PMID: 18996123.
        View in: PubMed
      155. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman S. Cancer epidemiology, biomarkers & prevention, and cancer prevention research: two journals, a common goal. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):2903-5. PMID: 18990728.
        View in: PubMed
      156. Ye Y, Lippman S, Lee JJ, Chen M, Frazier ML, Spitz MR, Wu X. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer. 2008 Nov 1; 113(9):2488-95. PMID: 18823025.
        View in: PubMed
      157. Rebbeck TR, Brown PH, Hawk ET, Lerman C, Paskett ED, Sellers TA, Lippman S. Cancer epidemiology, biomarkers & prevention and cancer prevention research: two journals, a common goal. Cancer Prev Res (Phila). 2008 Nov; 1(6):393-5. PMID: 19138984.
        View in: PubMed
      158. Howe LR, Lippman S. Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. J Natl Cancer Inst. 2008 Oct 15; 100(20):1420-3. PMID: 18840814.
        View in: PubMed
      159. Herbst RS, Heymach JV, Lippman S. Lung cancer. N Engl J Med. 2008 Sep 25; 359(13):1367-80. PMID: 18815398.
        View in: PubMed
      160. Seo HS, Liu DD, Bekele BN, Kim MK, Pisters K, Lippman S, Wistuba II, Koo JS. Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 2008 Aug 1; 68(15):6065-73. PMID: 18676828.
        View in: PubMed
      161. Yang H, Lippman S, Huang M, Jack Lee J, Wang W, Spitz MR, Wu X. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer. 2008 Jul; 44(11):1603-11. PMID: 18579371.
        View in: PubMed
      162. Lippman S. Inaugural issue of Cancer Prevention Research. Cancer Prev Res (Phila). 2008 Jun; 1(1):1-3. PMID: 19138928.
        View in: PubMed
      163. Mandal M, Myers JN, Lippman S, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 2008 May 1; 112(9):2088-100. PMID: 18327819.
        View in: PubMed
      164. Thompson IM, Tangen CM, Parnes HL, Lippman S, Coltman CA. Does the level of prostate cancer risk affect cancer prevention with finasteride? Urology. 2008 May; 71(5):854-7. PMID: 18455628.
        View in: PubMed
      165. Goodwin JW, Green SJ, Moinpour CM, Bearden JD, Giguere JK, Jiang CS, Lippman S, Martino S, Albain KS. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol. 2008 Apr 1; 26(10):1650-6. PMID: 18375894.
        View in: PubMed
      166. Papadimitrakopoulou VA, William WN, Dannenberg AJ, Lippman S, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO. Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res. 2008 Apr 1; 14(7):2095-101. PMID: 18381950.
        View in: PubMed
      167. Svatek RS, Lee JJ, Roehrborn CG, Lippman S, Lotan Y. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis. Cancer. 2008 Mar 1; 112(5):1058-65. PMID: 18186497.
        View in: PubMed
      168. Kawaguchi H, El-Naggar AK, Papadimitrakopoulou V, Ren H, Fan YH, Feng L, Lee JJ, Kim E, Hong WK, Lippman S, Mao L. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. J Clin Oncol. 2008 Jan 20; 26(3):354-60. PMID: 18202409.
        View in: PubMed
      169. Zuo X, Shen L, Issa JP, Moy O, Morris JS, Lippman S, Shureiqi I. 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J. 2008 Jun; 22(6):1981-92. PMID: 18198215.
        View in: PubMed
      170. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman S. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 1; 14(1):224-9. PMID: 18172274.
        View in: PubMed
      171. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman S, Weber RS, Kripke ML, Wei Q. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 1; 13(21):6532-9. PMID: 17975167.
        View in: PubMed
      172. Hoque A, Parnes HL, Stefanek ME, Heymach JV, Brown PH, Lippman S. Meeting Report: Fifth Annual AACR Frontiers in Cancer Prevention Research. Cancer Res. 2007 Oct 1; 67(19):8989-93. PMID: 17895292.
        View in: PubMed
      173. Lucia MS, Epstein JI, Goodman PJ, Darke AK, Reuter VE, Civantos F, Tangen CM, Parnes HL, Lippman S, La Rosa FG, Kattan MW, Crawford ED, Ford LG, Coltman CA, Thompson IM. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Sep 19; 99(18):1375-83. PMID: 17848673.
        View in: PubMed
      174. Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman S, Lucia MS, Parnes HL, Coltman CA. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial. J Clin Oncol. 2007 Jul 20; 25(21):3076-81. PMID: 17634486.
        View in: PubMed
      175. Lippman S, Heymach JV. The convergent development of molecular-targeted drugs for cancer treatment and prevention. Clin Cancer Res. 2007 Jul 15; 13(14):4035-41. PMID: 17634526.
        View in: PubMed
      176. Moinpour CM, Darke AK, Donaldson GW, Thompson IM, Langley C, Ankerst DP, Patrick DL, Ware JE, Ganz PA, Shumaker SA, Lippman S, Coltman CA. Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. J Natl Cancer Inst. 2007 Jul 4; 99(13):1025-35. PMID: 17596576.
        View in: PubMed
      177. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman S, Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007 Jun 15; 13(12):3753-8. PMID: 17575242.
        View in: PubMed
      178. Gotay CC, Moinpour CM, Unger JM, Jiang CS, Coleman D, Martino S, Parker BJ, Bearden JD, Dakhil S, Gross HM, Lippman S, Albain KS. Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. J Clin Oncol. 2007 May 20; 25(15):2093-9. PMID: 17513815.
        View in: PubMed
      179. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman S. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. J Clin Oncol. 2007 May 20; 25(15):1974-8. PMID: 17513803.
        View in: PubMed
      180. Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, Lippman S, Coltman CA. Finasteride decreases the risk of prostatic intraepithelial neoplasia. J Urol. 2007 Jul; 178(1):107-9; discussion 110. PMID: 17499284.
        View in: PubMed
      181. Thompson IM, Tangen CM, Goodman PJ, Lucia MS, Parnes HL, Lippman S, Coltman CA. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. J Urol. 2007 May; 177(5):1749-52. PMID: 17437804.
        View in: PubMed
      182. Herbst RS, Lippman S. Molecular signatures of lung cancer--toward personalized therapy. N Engl J Med. 2007 Jan 4; 356(1):76-8. PMID: 17202459.
        View in: PubMed
      183. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, Lippman S. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2007 Mar; 21(3):743-53. PMID: 17167069.
        View in: PubMed
      184. Herberman RB, Pearce HL, Lippman S, Pyenson BS, Alberts DS. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need. Cancer Res. 2006 Dec 15; 66(24):11540-9. PMID: 17158189.
        View in: PubMed
      185. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman S, Platz EA, Pollak MN, Thompson IM, Kristal AR. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1977-83. PMID: 17035408.
        View in: PubMed
      186. Lippman S. The dilemma and promise of cancer chemoprevention. Nat Clin Pract Oncol. 2006 Oct; 3(10):523. PMID: 17019426.
        View in: PubMed
      187. Thompson IM, Chi C, Ankerst DP, Goodman PJ, Tangen CM, Lippman S, Lucia MS, Parnes HL, Coltman CA. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. J Natl Cancer Inst. 2006 Aug 16; 98(16):1128-33. PMID: 16912265.
        View in: PubMed
      188. Svatek RS, Lee JJ, Roehrborn CG, Lippman S, Lotan Y. The cost of prostate cancer chemoprevention: a decision analysis model. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1485-9. PMID: 16896037.
        View in: PubMed
      189. Marshall JR, Sakr W, Wood D, Berry D, Tangen C, Parker F, Thompson I, Lippman S, Lieberman R, Alberts D, Jarrard D, Coltman C, Greenwald P, Minasian L, Crawford ED. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 2006 Aug; 15(8):1479-84. PMID: 16896036.
        View in: PubMed
      190. Liang ZD, Lippman S, Wu TT, Lotan R, Xu XC. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA. Cancer Res. 2006 Jul 15; 66(14):7111-8. PMID: 16849557.
        View in: PubMed
      191. Wang LE, Hsu TC, Xiong P, Strom SS, Duvic M, Clayman GL, Weber RS, Lippman S, Goldberg LH, Wei Q. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205. PMID: 16841033.
        View in: PubMed
      192. Kelloff GJ, Lippman S, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward. Clin Cancer Res. 2006 Jun 15; 12(12):3661-97. PMID: 16778094.
        View in: PubMed
      193. Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER, Wade JL, Robidoux A, Margolese RG, James J, Lippman S, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006 Jun 21; 295(23):2727-41. PMID: 16754727.
        View in: PubMed
      194. The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. J Clin Oncol. 2006 Jun 20; 24(18):2948-57. PMID: 16702579.
        View in: PubMed
      195. Lippman S, Lee JJ, Martin JW, El-Naggar AK, Xu X, Shin DM, Thomas M, Mao L, Fritsche HA, Zhou X, Papadimitrakopoulou V, Khuri FR, Tran H, Clayman GL, Hittelman WN, Hong WK, Lotan R. Fenretinide activity in retinoid-resistant oral leukoplakia. Clin Cancer Res. 2006 May 15; 12(10):3109-14. PMID: 16707609.
        View in: PubMed
      196. Subbarayan V, Krieg P, Hsi LC, Kim J, Yang P, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman S, Menter DG. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Oncogene. 2006 Sep 28; 25(44):6015-25. PMID: 16682954.
        View in: PubMed
      197. Huang M, Spitz MR, Gu J, Lee JJ, Lin J, Lippman S, Wu X. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006 Oct; 27(10):2034-7. PMID: 16638786.
        View in: PubMed
      198. Khuri FR, Lee JJ, Lippman S, Kim ES, Cooper JS, Benner SE, Winn R, Pajak TF, Williams B, Shenouda G, Hodson I, Fu K, Shin DM, Vokes EE, Feng L, Goepfert H, Hong WK. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst. 2006 Apr 5; 98(7):441-50. PMID: 16595780.
        View in: PubMed
      199. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman S. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 1; 12(7 Pt 1):2178-84. PMID: 16609032.
        View in: PubMed
      200. Lippman S, Lee JJ. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture. Cancer Res. 2006 Mar 15; 66(6):2893-903. PMID: 16540634.
        View in: PubMed
      201. Li G, Yin W, Chamberlain R, Hewett-Emmett D, Roberts JN, Yang X, Lippman S, Clifford JL. Identification and characterization of the human retinoid X receptor alpha gene promoter. Gene. 2006 May 10; 372:118-27. PMID: 16517099.
        View in: PubMed
      202. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman S, Shureiqi I. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. 2006 Feb 23; 25(8):1225-41. PMID: 16288226.
        View in: PubMed
      203. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman S, Amos CI, Spitz MR, Wei Q. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31. PMID: 16368944.
        View in: PubMed
      204. Song S, Lippman S, Zou Y, Ye X, Ajani JA, Xu XC. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-beta 2 expression. Oncogene. 2005 Dec 15; 24(56):8268-76. PMID: 16170369.
        View in: PubMed
      205. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman S. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11486-92. PMID: 16357157.
        View in: PubMed
      206. Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman S. Statins and cancer prevention. Nat Rev Cancer. 2005 Dec; 5(12):930-42. PMID: 16341084.
        View in: PubMed
      207. Sabichi AL, Xu X, Lippman S. RARbeta1': primed to fight retinoid resistance in lung carcinogenesis. J Natl Cancer Inst. 2005 Nov 16; 97(22):1632-3. PMID: 16288110.
        View in: PubMed
      208. Thompson IM, Tangen CM, Klein EA, Lippman S. Phase III prostate cancer prevention trials: are the costs justified? J Clin Oncol. 2005 Nov 10; 23(32):8161-4. PMID: 16278467.
        View in: PubMed
      209. Hsi LC, Xi X, Wu Y, Lippman S. The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Mol Cancer Ther. 2005 Nov; 4(11):1740-6. PMID: 16275995.
        View in: PubMed
      210. Sudbø J, Lee JJ, Lippman S, Mork J, Sagen S, Flatner N, Ristimäki A, Sudbø A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet. 2005 Oct 15-21; 366(9494):1359-66. PMID: 16226613.
        View in: PubMed
      211. Mayne ST, Lippman S. Cigarettes: a smoking gun in cancer chemoprevention. J Natl Cancer Inst. 2005 Sep 21; 97(18):1319-21. PMID: 16174848.
        View in: PubMed
      212. Deguchi A, Xing SW, Shureiqi I, Yang P, Newman RA, Lippman S, Feinmark SJ, Oehlen B, Weinstein IB. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells. Cancer Res. 2005 Sep 15; 65(18):8442-7. PMID: 16166323.
        View in: PubMed
      213. Klein EA, Tangen CM, Goodman PJ, Lippman S, Thompson IM. Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited. J Clin Oncol. 2005 Oct 20; 23(30):7460-6. PMID: 16157937.
        View in: PubMed
      214. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7. PMID: 16148695.
        View in: PubMed
      215. Lippman S, Gibson N, Subbaramaiah K, Dannenberg AJ. Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways. Clin Cancer Res. 2005 Sep 1; 11(17):6097-9. PMID: 16144906.
        View in: PubMed
      216. Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman S, Menter DG. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res. 2005 Jul 15; 65(14):6189-98. PMID: 16024620.
        View in: PubMed
      217. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman S, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702. PMID: 16030104.
        View in: PubMed
      218. Hirsch FR, Lippman S. Advances in the biology of lung cancer chemoprevention. J Clin Oncol. 2005 May 10; 23(14):3186-97. PMID: 15886305.
        View in: PubMed
      219. Ewer MS, Lippman S. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005 May 1; 23(13):2900-2. PMID: 15860848.
        View in: PubMed
      220. Xu XC, Lee JJ, Wu TT, Hoque A, Ajani JA, Lippman S. Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):826-9. PMID: 15824151.
        View in: PubMed
      221. Ewart-Toland A, Dai Q, Gao YT, Nagase H, Dunlop MG, Farrington SM, Barnetson RA, Anton-Culver H, Peel D, Ziogas A, Lin D, Miao X, Sun T, Ostrander EA, Stanford JL, Langlois M, Chan JM, Yuan J, Harris CC, Bowman ED, Clayman GL, Lippman S, Lee JJ, Zheng W, Balmain A. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis. 2005 Aug; 26(8):1368-73. PMID: 15802297.
        View in: PubMed
      222. Lotan Y, Cadeddu JA, Lee JJ, Roehrborn CG, Lippman S. Implications of the prostate cancer prevention trial: a decision analysis model of survival outcomes. J Clin Oncol. 2005 Mar 20; 23(9):1911-20. PMID: 15774783.
        View in: PubMed
      223. Subbarayan V, Xu XC, Kim J, Yang P, Hoque A, Sabichi AL, Llansa N, Mendoza G, Logothetis CJ, Newman RA, Lippman S, Menter DG. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia. Neoplasia. 2005 Mar; 7(3):280-93. PMID: 15799828.
        View in: PubMed
      224. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman S. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005 Feb 1; 23(4):759-65. PMID: 15681519.
        View in: PubMed
      225. Hoque A, Lippman S, Wu TT, Xu Y, Liang ZD, Swisher S, Zhang H, Cao L, Ajani JA, Xu XC. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis. 2005 Apr; 26(4):785-91. PMID: 15661803.
        View in: PubMed
      226. Lippman S, Goodman PJ, Klein EA, Parnes HL, Thompson IM, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005 Jan 19; 97(2):94-102. PMID: 15657339.
        View in: PubMed
      227. Lippman S, Levin B. Cancer prevention: strong science and real medicine. J Clin Oncol. 2005 Jan 10; 23(2):249-53. PMID: 15637388.
        View in: PubMed
      228. Dannenberg AJ, Lippman S, Mann JR, Subbaramaiah K, DuBois RN. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol. 2005 Jan 10; 23(2):254-66. PMID: 15637389.
        View in: PubMed
      229. Lippman S, Sudbø J, Hong WK. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol. 2005 Jan 10; 23(2):346-56. PMID: 15637397.
        View in: PubMed
      230. Cook ED, Moody-Thomas S, Anderson KB, Campbell R, Hamilton SJ, Harrington JM, Lippman S, Minasian LM, Paskett ED, Craine S, Arnold KB, Probstfield JL. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Clin Trials. 2005; 2(5):436-42. PMID: 16315648.
        View in: PubMed
      231. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman S. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res. 2004 Dec 1; 64(23):8778-81. PMID: 15574791.
        View in: PubMed
      232. Duffield-Lillico AJ, Shureiqi I, Lippman S. Can selenium prevent colorectal cancer? A signpost from epidemiology. J Natl Cancer Inst. 2004 Nov 17; 96(22):1645-7. PMID: 15547171.
        View in: PubMed
      233. Sabichi AL, Subbarayan V, Llansa N, Lippman S, Menter DG. Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1704-9. PMID: 15533896.
        View in: PubMed
      234. Subbarayan V, Sabichi AL, Kim J, Llansa N, Logothetis CJ, Lippman S, Menter DG. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1710-6. PMID: 15533897.
        View in: PubMed
      235. Abbruzzese JL, Lippman S. The convergence of cancer prevention and therapy in early-phase clinical drug development. Cancer Cell. 2004 Oct; 6(4):321-6. PMID: 15488755.
        View in: PubMed
      236. Lippman S, Levin B, Brenner DE, Gordon GB, Aldige CR, Kramer BS, Garber JE, Hawk E, Ganz PA, Somerfield MR. Cancer prevention and the American Society of Clinical Oncology. J Clin Oncol. 2004 Oct 1; 22(19):3848-51. PMID: 15353541.
        View in: PubMed
      237. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman S, Crawford ED, Crowley JJ, Coltman CA. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004 May 27; 350(22):2239-46. PMID: 15163773.
        View in: PubMed
      238. Taylor PR, Parnes HL, Lippman S. Science peels the onion of selenium effects on prostate carcinogenesis. J Natl Cancer Inst. 2004 May 5; 96(9):645-7. PMID: 15126594.
        View in: PubMed
      239. Sabichi AL, Lippman S. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol. 2004 Apr; 31(2 Suppl 7):36-44. PMID: 15179622.
        View in: PubMed
      240. Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, Lippman S, Sahin A. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Int J Oncol. 2004 Apr; 24(4):879-84. PMID: 15010825.
        View in: PubMed
      241. Sudbø J, Lippman S, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med. 2004 Apr 1; 350(14):1405-13. PMID: 15070790.
        View in: PubMed
      242. Youssef EM, Lotan D, Issa JP, Wakasa K, Fan YH, Mao L, Hassan K, Feng L, Lee JJ, Lippman S, Hong WK, Lotan R. Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res. 2004 Mar 1; 10(5):1733-42. PMID: 15014026.
        View in: PubMed
      243. Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman S, Frye R, Cavanaugh PF. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 1; 10(5):1565-73. PMID: 15014005.
        View in: PubMed
      244. Salas TR, Kim J, Vakar-Lopez F, Sabichi AL, Troncoso P, Jenster G, Kikuchi A, Chen SY, Shemshedini L, Suraokar M, Logothetis CJ, DiGiovanni J, Lippman S, Menter DG. Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity. J Biol Chem. 2004 Apr 30; 279(18):19191-200. PMID: 14985354.
        View in: PubMed
      245. Thompson IM, Klein EA, Lippman S, Coltman CA, Djavan B. Prevention of prostate cancer with finasteride: US/European perspective. Eur Urol. 2003 Dec; 44(6):650-5. PMID: 14644115.
        View in: PubMed
      246. Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman S. Molecular based treatment of oral cancer. Oral Oncol. 2003 Dec; 39(8):749-58. PMID: 13679198.
        View in: PubMed
      247. Hoque A, Carter J, Xia W, Hung MC, Sahin AA, Sen S, Lippman S. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol Biomarkers Prev. 2003 Dec; 12(12):1518-22. PMID: 14693746.
        View in: PubMed
      248. Papadimitrakopoulou VA, Ginsberg LE, Garden AS, Kies MS, Glisson BS, Diaz EM, Clayman G, Morrison WH, Liu DD, Blumenschein G, Lippman S, Schommer D, Gillenwater A, Goepfert H, Hong WK. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma. Cancer. 2003 Nov 15; 98(10):2214-23. PMID: 14601092.
        View in: PubMed
      249. Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman S, Recant W, El-Naggar AK, Stenson K, Lippman S, Hong WK, Vokes EE. An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol. 2003 Dec 15; 21(24):4546-52. PMID: 14597742.
        View in: PubMed
      250. Chu DZ, Chansky K, Alberts DS, Meyskens FL, Fenoglio-Preiser CM, Rivkin SE, Mills GM, Giguere JK, Goodman GE, Abbruzzese JL, Lippman S. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study. Ann Surg Oncol. 2003 Oct; 10(8):870-5. PMID: 14527904.
        View in: PubMed
      251. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003 Oct; 76(4):1001-7; discussion 1007-8. PMID: 14529975.
        View in: PubMed
      252. Jiang F, Caraway NP, Sabichi AL, Zhang HZ, Ruitrok A, Grossman HB, Gu J, Lerner SP, Lippman S, Katz RL. Centrosomal abnormality is common in and a potential biomarker for bladder cancer. Int J Cancer. 2003 Sep 20; 106(5):661-5. PMID: 12866024.
        View in: PubMed
      253. Sabichi AL, Demierre MF, Hawk ET, Lerman CE, Lippman S. Frontiers in cancer prevention research. Cancer Res. 2003 Sep 15; 63(18):5649-55. PMID: 14522879.
        View in: PubMed
      254. Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman S, Bast RC, Yu Y. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res. 2003 Sep 1; 9(10 Pt 1):3660-6. PMID: 14506155.
        View in: PubMed
      255. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman S. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9968-73. PMID: 12909723.
        View in: PubMed
      256. Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman S, Menter DG. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei. J Biol Chem. 2003 Oct 17; 278(42):41338-46. PMID: 12900420.
        View in: PubMed
      257. Sabichi AL, Modiano MR, Lee JJ, Peng YM, Xu MJ, Villar H, Dalton WS, Lippman S. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide. Clin Cancer Res. 2003 Jul; 9(7):2400-5. PMID: 12855611.
        View in: PubMed
      258. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman S, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003 Jul 17; 349(3):215-24. PMID: 12824459.
        View in: PubMed
      259. Clifford JL, Yang X, Walch E, Wang M, Lippman S. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells. Mol Cancer Ther. 2003 May; 2(5):453-9. PMID: 12748307.
        View in: PubMed
      260. Liang Z, Lippman S, Kawabe A, Shimada Y, Xu XC. Identification of benzo(a)pyrene diol epoxide-binding DNA fragments using DNA immunoprecipitation technique. Cancer Res. 2003 Apr 1; 63(7):1470-4. PMID: 12670892.
        View in: PubMed
      261. Klein EA, Lippman S, Thompson IM, Goodman PJ, Albanes D, Taylor PR, Coltman C. The selenium and vitamin E cancer prevention trial. World J Urol. 2003 May; 21(1):21-7. PMID: 12756490.
        View in: PubMed
      262. Xu XC, Shappell SB, Liang Z, Song S, Menter D, Subbarayan V, Iyengar S, Tang DG, Lippman S. Reduced 15S-lipoxygenase-2 expression in esophageal cancer specimens and cells and upregulation in vitro by the cyclooxygenase-2 inhibitor, NS398. Neoplasia. 2003 Mar-Apr; 5(2):121-7. PMID: 12659684.
        View in: PubMed
      263. Bolshakov S, Walker CM, Strom SS, Selvan MS, Clayman GL, El-Naggar A, Lippman S, Kripke ML, Ananthaswamy HN. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res. 2003 Jan; 9(1):228-34. PMID: 12538474.
        View in: PubMed
      264. Sabichi AL, Lippman S. COX-2 inhibitors and other NSAIDs in bladder and prostate cancer. Prog Exp Tumor Res. 2003; 37:163-78. PMID: 12795054.
        View in: PubMed
      265. Klein EA, Thompson IM, Lippman S, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol. 2003 Jan-Feb; 21(1):59-65. PMID: 12684129.
        View in: PubMed
      266. Lippman S, Hong WK. Cancer prevention science and practice. Cancer Res. 2002 Sep 15; 62(18):5119-25. PMID: 12234971.
        View in: PubMed
      267. Singletary SE, Atkinson EN, Hoque A, Sneige N, Sahin AA, Fritsche HA, Lotan R, Lu T, Hittelman WN, Bevers TB, Stelling CB, Lippman S. Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res. 2002 Sep; 8(9):2835-42. PMID: 12231524.
        View in: PubMed
      268. Shin DM, Glisson BS, Khuri FR, Lippman S, Ginsberg L, Diaz E, Papadimitrakopoulou V, Feng L, Francisco M, Garden A, Kies MS, Myers J, Clayman G, Hong WK. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30. PMID: 12124833.
        View in: PubMed
      269. Clifford JL, Walch E, Yang X, Xu X, Alberts DS, Clayman GL, El-Naggar AK, Lotan R, Lippman S. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res. 2002 Jul; 8(7):2067-72. PMID: 12114405.
        View in: PubMed
      270. Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman S. Her-2/neu gene amplification in ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2002 Jun; 11(6):587-90. PMID: 12050101.
        View in: PubMed
      271. Wu X, Lippman S, Lee JJ, Zhu Y, Wei QV, Thomas M, Hong WK, Spitz MR. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002 May 15; 62(10):2813-8. PMID: 12019158.
        View in: PubMed
      272. Shureiqi I, Jiang W, Fischer SM, Xu X, Chen D, Lee JJ, Lotan R, Lippman S. GATA-6 transcriptional regulation of 15-lipoxygenase-1 during NSAID-induced apoptosis in colorectal cancer cells. Cancer Res. 2002 Feb 15; 62(4):1178-83. PMID: 11861401.
        View in: PubMed
      273. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman S, Von Hoff DD. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 2002 Feb; 8(2):314-46. PMID: 11839647.
        View in: PubMed
      274. Lippman S, Hong WK. Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002. Clin Cancer Res. 2002 Feb; 8(2):305-13. PMID: 11839646.
        View in: PubMed
      275. Shureiqi I, Cantor SB, Lippman S, Brenner DE, Chernew ME, Fendrick AM. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy. Br J Cancer. 2002 Jan 21; 86(2):226-32. PMID: 11870511.
        View in: PubMed
      276. Li M, Song S, Lippman S, Zhang XK, Liu X, Lotan R, Xu XC. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene. 2002 Jan 17; 21(3):411-8. PMID: 11821953.
        View in: PubMed
      277. Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman S. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol. 2002 Jan 15; 20(2):364-70. PMID: 11786562.
        View in: PubMed
      278. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn. 2001 Nov; 3(4):164-70. PMID: 11687600.
        View in: PubMed
      279. Follen M, Atkinson EN, Schottenfeld D, Malpica A, West L, Lippman S, Zou C, Hittelman WN, Lotan R, Hong WK. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix. Clin Cancer Res. 2001 Nov; 7(11):3356-65. PMID: 11705848.
        View in: PubMed
      280. Klein EA, Thompson IM, Lippman S, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol. 2001 Oct; 166(4):1311-5. PMID: 11547064.
        View in: PubMed
      281. Lippman S, Spitz MR. Lung cancer chemoprevention: an integrated approach. J Clin Oncol. 2001 Sep 15; 19(18 Suppl):74S-82S. PMID: 11560978.
        View in: PubMed
      282. Shureiqi I, Lippman S. Lipoxygenase modulation to reverse carcinogenesis. Cancer Res. 2001 Sep 1; 61(17):6307-12. PMID: 11522616.
        View in: PubMed
      283. Hoque A, Albanes D, Lippman S, Spitz MR, Taylor PR, Klein EA, Thompson IM, Goodman P, Stanford JL, Crowley JJ, Coltman CA, Santella RM. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control. 2001 Sep; 12(7):627-33. PMID: 11552710.
        View in: PubMed
      284. Shureiqi I, Cooksley CD, Morris J, Soliman AS, Levin B, Lippman S. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst. 2001 Aug 15; 93(16):1264-6. PMID: 11504772.
        View in: PubMed
      285. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman S, Fu KK, Cooper JS, Vokes EE, Chamberlain RM, Williams B, Pajak TF, Goepfert H, Hong WK. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001 Aug; 10(8):823-9. PMID: 11489748.
        View in: PubMed
      286. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman S. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 2001 Jun 15; 61(12):4879-84. PMID: 11406566.
        View in: PubMed
      287. Shin DM, Khuri FR, Murphy B, Garden AS, Clayman G, Francisco M, Liu D, Glisson BS, Ginsberg L, Papadimitrakopoulou V, Myers J, Morrison W, Gillenwater A, Ang KK, Lippman S, Goepfert H, Hong WK. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J Clin Oncol. 2001 Jun 15; 19(12):3010-7. PMID: 11408495.
        View in: PubMed
      288. Menter DG, Hoque A, Motiwala N, Sahin AA, Sneige N, Lieberman R, Lippman S. Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. Anal Quant Cytol Histol. 2001 Jun; 23(3):218-28. PMID: 11444192.
        View in: PubMed
      289. Sun SY, Yue P, Kelloff GJ, Steele VE, Lippman S, Hong WK, Lotan R. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells. Cancer Epidemiol Biomarkers Prev. 2001 Jun; 10(6):595-601. PMID: 11401908.
        View in: PubMed
      290. Shin DM, Charuruks N, Lippman S, Lee JJ, Ro JY, Hong WK, Hittelman WN. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis. Cancer Epidemiol Biomarkers Prev. 2001 Jun; 10(6):603-9. PMID: 11401909.
        View in: PubMed
      291. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, Alberts DS, Lippman S, Lotan R. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res. 2001 Jun 1; 61(11):4306-10. PMID: 11389049.
        View in: PubMed
      292. El-Naggar AK, Lai S, Clayman GL, Mims B, Lippman S, Coombes M, Luna MA, Lozano G. p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas. Carcinogenesis. 2001 May; 22(5):729-35. PMID: 11323391.
        View in: PubMed
      293. Lippman S, Hong WK. Molecular markers of the risk of oral cancer. N Engl J Med. 2001 Apr 26; 344(17):1323-6. PMID: 11320393.
        View in: PubMed
      294. Lippman S, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001 Apr 18; 93(8):605-18. PMID: 11309437.
        View in: PubMed
      295. Khuri FR, Lee JS, Lippman S, Lee JJ, Kalapurakal S, Yu R, Ro JY, Morice RC, Hong WK, Hittelman WN. Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):311-8. PMID: 11319170.
        View in: PubMed
      296. Kim J, Shin DM, El-Naggar A, Lee JS, Corrales C, Lippman S, Hong WK, Hittelman WN. Chromosome polysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):319-25. PMID: 11319171.
        View in: PubMed
      297. Clifford JL, Sabichi AL, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Lippman S. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):391-5. PMID: 11319181.
        View in: PubMed
      298. Shin DM, Khuri FR, Glisson BS, Ginsberg L, Papadimitrakopoulou VM, Clayman G, Lee JJ, Ang KK, Lippman S, Hong WK. Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma. Cancer. 2001 Apr 1; 91(7):1316-23. PMID: 11283932.
        View in: PubMed
      299. Lieberman R, Nelson WG, Sakr WA, Meyskens FL, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman S. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations. Urology. 2001 Apr; 57(4 Suppl 1):4-27. PMID: 11295590.
        View in: PubMed
      300. Lee JJ, Lieberman R, Sloan JA, Piantadosi S, Lippman S. Design considerations for efficient prostate cancer chemoprevention trials. Urology. 2001 Apr; 57(4 Suppl 1):205-12. PMID: 11295629.
        View in: PubMed
      301. Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman S, Feng L, Hong WK, Xu XC. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 2001 Apr; 7(4):861-7. PMID: 11309334.
        View in: PubMed
      302. Subbarayan V, Sabichi AL, Llansa N, Lippman S, Menter DG. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Res. 2001 Mar 15; 61(6):2720-6. PMID: 11289153.
        View in: PubMed
      303. Hoque A, Lippman S, Boiko IV, Atkinson EN, Sneige N, Sahin A, Weber DM, Risin S, Lagios MD, Schwarting R, Colburn WJ, Dhingra K, Follen M, Kelloff GJ, Boone CW, Hittelman WN. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev. 2001 Mar; 10(3):249-59. PMID: 11303595.
        View in: PubMed
      304. Hoque A, Menter DG, Sahin AA, Sneige N, Lippman S. No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2001 Feb; 10(2):153-4. PMID: 11219775.
        View in: PubMed
      305. Clayman GL, Johnson CJ, Morrison W, Ginsberg L, Lippman S. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):135-9. PMID: 11177029.
        View in: PubMed
      306. Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman S. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res. 2000 Dec 15; 60(24):6846-50. PMID: 11156377.
        View in: PubMed
      307. Lippman S, Matrisian LM. Protease inhibitors in oral carcinogenesis and chemoprevention. Clin Cancer Res. 2000 Dec; 6(12):4599-603. PMID: 11156207.
        View in: PubMed
      308. Hong WK, Spitz MR, Lippman S. Cancer chemoprevention in the 21st century: genetics, risk modeling, and molecular targets. J Clin Oncol. 2000 Nov 1; 18(21 Suppl):9S-18S. PMID: 11060320.
        View in: PubMed
      309. Menter DG, Sabichi AL, Lippman S. Selenium effects on prostate cell growth. Cancer Epidemiol Biomarkers Prev. 2000 Nov; 9(11):1171-82. PMID: 11097224.
        View in: PubMed
      310. Klein EA, Thompson IM, Lippman S, Goodman PJ, Albanes D, Taylor PR, Coltman C. SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design. Prostate Cancer Prostatic Dis. 2000 Nov; 3(3):145-151. PMID: 12497090.
        View in: PubMed
      311. Singletary E, Lieberman R, Atkinson N, Sneige N, Sahin A, Tolley S, Colchin M, Bevers T, Stelling C, Fornage B, Fritsche H, Hittelman W, Kelloff G, Lippman S. Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1087-90. PMID: 11045792.
        View in: PubMed
      312. Shalev M, Thompson TC, Frolov A, Lippman S, Hong WK, Fritsche H, Kadmon D. Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy. Clin Cancer Res. 2000 Oct; 6(10):3845-9. PMID: 11051228.
        View in: PubMed
      313. Clifford JL, Menter DG, Yang X, Walch E, Zou C, Clayman GL, Schaefer TS, El-Naggar AK, Lotan R, Lippman S. Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev. 2000 Sep; 9(9):993-7. PMID: 11008921.
        View in: PubMed
      314. Hawk ET, Lippman S. Primary cancer prevention trials. Hematol Oncol Clin North Am. 2000 Aug; 14(4):809-30. PMID: 10949775.
        View in: PubMed
      315. Khuri FR, Shin DM, Glisson BS, Lippman S, Hong WK. Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol. 2000 Aug; 27(4 Suppl 8):25-33. PMID: 10952435.
        View in: PubMed
      316. Duvic M, Helekar B, Schulz C, Cho M, DiSepio D, Hager C, DiMao D, Hazarika P, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman S, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S. Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res. 2000 Aug; 6(8):3249-59. PMID: 10955811.
        View in: PubMed
      317. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman S, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu X, Lotan R, Hong WK. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res. 2000 Aug; 6(8):2973-9. PMID: 10955773.
        View in: PubMed
      318. Khuri FR, Lotan R, Kemp BL, Lippman S, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol. 2000 Aug; 18(15):2798-804. PMID: 10920126.
        View in: PubMed
      319. Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman S. 15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst. 2000 Jul 19; 92(14):1136-42. PMID: 10904086.
        View in: PubMed
      320. Brown PH, Lippman S. Chemoprevention of breast cancer. Breast Cancer Res Treat. 2000 Jul; 62(1):1-17. PMID: 10989982.
        View in: PubMed
      321. Qiu H, Lotan R, Lippman S, Xu XC. Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer. Genes Chromosomes Cancer. 2000 Jun; 28(2):196-202. PMID: 10825004.
        View in: PubMed
      322. Li M, Lotan R, Levin B, Tahara E, Lippman S, Xu XC. Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol Biomarkers Prev. 2000 Jun; 9(6):545-9. PMID: 10868686.
        View in: PubMed
      323. Wu H, Lotan R, Menter D, Lippman S, Xu XC. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Anticancer Res. 2000 May-Jun; 20(3A):1385-90. PMID: 10928048.
        View in: PubMed
      324. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman S. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000 May; 6(5):1702-10. PMID: 10815888.
        View in: PubMed
      325. Li G, Walch E, Yang X, Lippman S, Clifford JL. Cloning and characterization of the human retinoid X receptor alpha gene: conservation of structure with the mouse homolog. Biochem Biophys Res Commun. 2000 Mar 5; 269(1):54-7. PMID: 10694476.
        View in: PubMed
      326. Khuri FR, Lippman S. Lung cancer chemoprevention. Semin Surg Oncol. 2000 Mar; 18(2):100-5. PMID: 10657911.
        View in: PubMed
      327. Lippman S, Lotan R. Advances in the development of retinoids as chemopreventive agents. J Nutr. 2000 Feb; 130(2S Suppl):479S-482S. PMID: 10721933.
        View in: PubMed
      328. Shin DM, Mao L, Papadimitrakopoulou VM, Clayman G, El-Naggar A, Shin HJ, Lee JJ, Lee JS, Gillenwater A, Myers J, Lippman S, Hittelman WN, Hong WK. Biochemopreventive therapy for patients with premalignant lesions of the head and neck and p53 gene expression. J Natl Cancer Inst. 2000 Jan 5; 92(1):69-73. PMID: 10620636.
        View in: PubMed
      329. Bacus JW, Boone CW, Bacus JV, Follen M, Kelloff GJ, Kagan V, Lippman S. Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1087-94. PMID: 10613341.
        View in: PubMed
      330. Lippman S, Brown PH. Tamoxifen prevention of breast cancer: an instance of the fingerpost. J Natl Cancer Inst. 1999 Nov 3; 91(21):1809-19. PMID: 10547388.
        View in: PubMed
      331. Qiu H, Zhang W, El-Naggar AK, Lippman S, Lin P, Lotan R, Xu XC. Loss of retinoic acid receptor-beta expression is an early event during esophageal carcinogenesis. Am J Pathol. 1999 Nov; 155(5):1519-23. PMID: 10550308.
        View in: PubMed
      332. McCaskill-Stevens W, Hawk ET, Flynn PJ, Lippman S. National Cancer Institute--supported cancer chemoprevention research: coming of age. J Clin Oncol. 1999 Nov; 17(11 Suppl):53-62. PMID: 10630263.
        View in: PubMed
      333. Papadimitrakopoulou VA, Clayman GL, Shin DM, Myers JN, Gillenwater AM, Goepfert H, El-Naggar AK, Lewin JS, Lippman S, Hong WK. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1999 Oct; 125(10):1083-9. PMID: 10522499.
        View in: PubMed
      334. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman S, Hong WK, Lotan R. Nuclear retinoid acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst. 1999 Aug 4; 91(15):1317-21. PMID: 10433621.
        View in: PubMed
      335. Garden AS, Glisson BS, Ang KK, Morrison WH, Lippman S, Byers RM, Geara F, Clayman GL, Shin DM, Callender DL, Khuri FR, Goepfert H, Hong WK, Peters LJ. Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol. 1999 Aug; 17(8):2390-5. PMID: 10561301.
        View in: PubMed
      336. Sun SY, Li W, Yue P, Lippman S, Hong WK, Lotan R. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res. 1999 May 15; 59(10):2493-8. PMID: 10344763.
        View in: PubMed
      337. Xu XC, Liu X, Tahara E, Lippman S, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999 May 15; 59(10):2477-83. PMID: 10344761.
        View in: PubMed
      338. Sneige N, Lagios MD, Schwarting R, Colburn W, Atkinson E, Weber D, Sahin A, Kemp B, Hoque A, Risin S, Sabichi A, Boone C, Dhingra K, Kelloff G, Lippman S. Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. Hum Pathol. 1999 Mar; 30(3):257-62. PMID: 10088542.
        View in: PubMed
      339. Shin DM, Lippman S. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions. Semin Oncol. 1999 Feb; 26(1 Suppl 2):100-5. PMID: 10190789.
        View in: PubMed
      340. Clifford JL, Menter DG, Wang M, Lotan R, Lippman S. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res. 1999 Jan 1; 59(1):14-8. PMID: 9892176.
        View in: PubMed
      341. Singh DK, Lippman S. Cancer chemoprevention. Part 2: Hormones, nonclassic antioxidant natural agents, NSAIDs, and other agents. Oncology (Williston Park). 1998 Dec; 12(12):1787-800; discussion 1802, 1805. PMID: 9874850.
        View in: PubMed
      342. Weiss GR, Liu PY, Alberts DS, Peng YM, Fisher E, Xu MJ, Scudder SA, Baker LH, Moore DF, Lippman S. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Gynecol Oncol. 1998 Dec; 71(3):386-90. PMID: 9887236.
        View in: PubMed
      343. Singh DK, Lippman S. Cancer chemoprevention. Part 1: Retinoids and carotenoids and other classic antioxidants. Oncology (Williston Park). 1998 Nov; 12(11):1643-53, 1657-8; discussion 1659-60. PMID: 9834941.
        View in: PubMed
      344. Lippman S, Lee JJ, Sabichi AL. Cancer chemoprevention: progress and promise. J Natl Cancer Inst. 1998 Oct 21; 90(20):1514-28. PMID: 9790544.
        View in: PubMed
      345. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, Zhou X, Clayman G, Lee JJ, Lee JS, Hittelman WN, Lippman S, Hong WK. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst. 1998 Oct 21; 90(20):1545-51. PMID: 9790547.
        View in: PubMed
      346. Sabichi AL, Lerner SP, Grossman HB, Lippman S. Retinoids in the chemoprevention of bladder cancer. Curr Opin Oncol. 1998 Sep; 10(5):479-84. PMID: 9800121.
        View in: PubMed
      347. Zhou J, Mulshine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman S, Lee JS. Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers. Clin Cancer Res. 1998 Jul; 4(7):1631-40. PMID: 9676837.
        View in: PubMed
      348. Clayman GL, el-Naggar AK, Lippman S, Henderson YC, Frederick M, Merritt JA, Zumstein LA, Timmons TM, Liu TJ, Ginsberg L, Roth JA, Hong WK, Bruso P, Goepfert H. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Jun; 16(6):2221-32. PMID: 9626224.
        View in: PubMed
      349. Shin DM, Glisson BS, Khuri FR, Hong WK, Lippman S. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PMID: 9578061.
        View in: PubMed
      350. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Papadimitrakopoulou V, Lee JJ, Lawhorn K, Gillenwater AM, Ang KK, Clayman GL, Callender DL, Hong WK, Lippman S. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998 Apr; 16(4):1325-30. PMID: 9552033.
        View in: PubMed
      351. Spitz MR, Lippman S, Jiang H, Lee JJ, Khuri F, Hsu TC, Trizna Z, Schantz SP, Benner S, Hong WK. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998 Feb 4; 90(3):243-5. PMID: 9462683.
        View in: PubMed
      352. Brockstein B, Haraf DJ, Stenson K, Fasanmade A, Stupp R, Glisson B, Lippman S, Ratain MJ, Sulzen L, Klepsch A, Weichselbaum RR, Vokes EE. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. J Clin Oncol. 1998 Feb; 16(2):735-44. PMID: 9469365.
        View in: PubMed
      353. Shade RJ, Pisters KM, Huber MH, Fossella F, Perez-Soler R, Shin DM, Kurie J, Glisson B, Lippman S, Lee JS. Phase I study of paclitaxel administered by ten-day continuous infusion. Invest New Drugs. 1998-1999; 16(3):237-43. PMID: 10360603.
        View in: PubMed
      354. Lippman S, Benner SE, Fritsche HA, Lee JS, Hong WK. The effect of 13-cis-retinoic acid chemoprevention on human serum retinol levels. Cancer Detect Prev. 1998; 22(1):51-6. PMID: 9466049.
        View in: PubMed
      355. Shin DM, Glisson BS, Khuri FR, Ginsberg L, Lawhorn K, Hong WK, Lippman S. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PMID: 9427263.
        View in: PubMed
      356. Xu XC, Sneige N, Liu X, Nandagiri R, Lee JJ, Lukmanji F, Hortobagyi G, Lippman S, Dhingra K, Lotan R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997 Nov 15; 57(22):4992-6. PMID: 9371489.
        View in: PubMed
      357. Farmer KL, Goller M, Lippman S. Prevention of nonmelanoma skin cancer. Standard and investigative approaches. Clin Plast Surg. 1997 Oct; 24(4):663-71. PMID: 9342509.
        View in: PubMed
      358. Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman S, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK. Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):687-92. PMID: 9298575.
        View in: PubMed
      359. Mao L, Lee JS, Kurie JM, Fan YH, Lippman S, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997 Jun 18; 89(12):857-62. PMID: 9196251.
        View in: PubMed
      360. Shin DM, Xu XC, Lippman S, Lee JJ, Lee JS, Batsakis JG, Ro JY, Martin JW, Hittelman WN, Lotan R, Hong WK. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention. Clin Cancer Res. 1997 Jun; 3(6):875-80. PMID: 9815762.
        View in: PubMed
      361. Papadimitrakopoulou V, Izzo J, Lippman S, Lee JS, Fan YH, Clayman G, Ro JY, Hittelman WN, Lotan R, Hong WK, Mao L. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene. 1997 Apr 17; 14(15):1799-803. PMID: 9150385.
        View in: PubMed
      362. Geara FB, Glisson BS, Sanguineti G, Tucker SL, Garden AS, Ang KK, Lippman S, Clayman GL, Goepfert H, Peters LJ, Hong WK. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study. Cancer. 1997 Apr 1; 79(7):1279-86. PMID: 9083147.
        View in: PubMed
      363. Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman S. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Cancer J Sci Am. 1997 Mar-Apr; 3(2):92-9. PMID: 9099459.
        View in: PubMed
      364. Lippman S, Lotan R, Schleuniger U. Retinoid-interferon therapy of solid tumors. Int J Cancer. 1997 Feb 7; 70(4):481-3. PMID: 9033661.
        View in: PubMed
      365. Khuri FR, Lippman S, Spitz MR, Lotan R, Hong WK. Molecular epidemiology and retinoid chemoprevention of head and neck cancer. J Natl Cancer Inst. 1997 Feb 5; 89(3):199-211. PMID: 9017000.
        View in: PubMed
      366. Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, Batsakis JG, Lippman S. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst. 1997 Feb 5; 89(3):257-8. PMID: 9017007.
        View in: PubMed
      367. Ford M, Martin RD, Hilton LW, Ewert-Flannagan T, Corrigan GK, Johnson G, Hernandez MA, Sbach A, Lippman S. Outcomes study of a course in breast-cancer screening. J Cancer Educ. 1997; 12(3):179-84. PMID: 9376257.
        View in: PubMed
      368. Dimery IW, Hong WK, Lee JJ, Guillory-Perez C, Pham F, Fritsche HA, Lippman S. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann Oncol. 1997 Jan; 8(1):85-9. PMID: 9093712.
        View in: PubMed
      369. Fossella FV, Lippman S, Shin DM, Tarassoff P, Calayag-Jung M, Perez-Soler R, Lee JS, Murphy WK, Glisson B, Rivera E, Hong WK. Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer. J Clin Oncol. 1997 Jan; 15(1):310-6. PMID: 8996158.
        View in: PubMed
      370. Lippman S, Davies PJ. Retinoids, neoplasia and differentiation therapy. Cancer Chemother Biol Response Modif. 1997; 17:349-62. PMID: 9551220.
        View in: PubMed
      371. Chamberlain RM, Williams J, Levin B, Lippman S. Cancer prevention education at the M. D. Anderson Cancer Center. J Cancer Educ. 1997; 12(3):141-8. PMID: 9376250.
        View in: PubMed
      372. Mao L, El-Naggar AK, Fan YH, Lee JS, Lippman S, Kayser S, Lotan R, Hong WK. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res. 1996 Dec 15; 56(24):5600-4. PMID: 8971162.
        View in: PubMed
      373. Garden AS, Lippman S, Morrison WH, Glisson BS, Ang KK, Geara F, Hong WK, Peters LJ. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys. 1996 Dec 1; 36(5):1005-12. PMID: 8985020.
        View in: PubMed
      374. Kurie JM, Shin HJ, Lee JS, Morice RC, Ro JY, Lippman S, Hittelman WN, Yu R, Lee JJ, Hong WK. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res. 1996 Oct; 2(10):1787-93. PMID: 9816131.
        View in: PubMed
      375. Huber MH, Lippman S, Benner SE, Shirinian M, Dimery IW, Dunnington JS, Hong WK. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol. 1996 Aug; 19(4):379-82. PMID: 8677909.
        View in: PubMed
      376. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, Hittelman W, Hong WK. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996 Jun; 2(6):682-5. PMID: 8640560.
        View in: PubMed
      377. Shin DM, Lee JS, Lippman S, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996 Apr 17; 88(8):519-29. PMID: 8606380.
        View in: PubMed
      378. Lippman S, Kalvakolanu DV, Lotan R. Retinoids and interferons in non-melanoma skin cancer. J Investig Dermatol Symp Proc. 1996 Apr; 1(2):219-22. PMID: 9627720.
        View in: PubMed
      379. Kurie JM, Lee JS, Griffin T, Lippman S, Drum P, Thomas MP, Weber C, Bader M, Massimini G, Hong WK. Phase I trial of 9-cis retinoic acid in adults with solid tumors. Clin Cancer Res. 1996 Feb; 2(2):287-93. PMID: 9816171.
        View in: PubMed
      380. Perez-Soler R, Fossella FV, Glisson BS, Lee JS, Murphy WK, Shin DM, Kemp BL, Lee JJ, Kane J, Robinson RA, Lippman S, Kurie JM, Huber MH, Raber MN, Hong WK. Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy. J Clin Oncol. 1996 Feb; 14(2):503-13. PMID: 8636764.
        View in: PubMed
      381. Huber MH, Lee JS, Newman RA, Fossella FV, Wester M, Hong WK, Lippman S. A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors. Ann Oncol. 1996 Jan; 7(1):59-63. PMID: 9081393.
        View in: PubMed
      382. Hittelman WN, Kim HJ, Lee JS, Shin DM, Lippman S, Kim J, Ro JY, Hong WK. Detection of chromosome instability of tissue fields at risk: in situ hybridization. J Cell Biochem Suppl. 1996; 25:57-62. PMID: 9027599.
        View in: PubMed
      383. Austin JR, Cebrun H, Kershisnik MM, El-Naggar AK, Garden AS, Demonte F, Ginsberg LE, Lippman S, Goepfert H. Olfactory neuroblastoma and neuroendocrine carcinoma of the anterior skull base: treatment results at the m.d. Anderson cancer center. Skull Base Surg. 1996; 6(1):1-8. PMID: 17170947.
        View in: PubMed
      384. Xu XC, Lee JS, Lippman S, Ro JY, Hong WK, Lotan R. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1995 Dec; 4(8):871-6. PMID: 8634660.
        View in: PubMed
      385. Moore DF, Pazdur R, Sugarman S, Jones D, Lippman S, Bready B, Abbruzzese JL. Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma. Am J Clin Oncol. 1995 Dec; 18(6):525-7. PMID: 8526197.
        View in: PubMed
      386. Xu XC, Zile MH, Lippman S, Lee JS, Lee JJ, Hong WK, Lotan R. Anti-retinoic acid (RA) antibody binding to human premalignant oral lesions, which occurs less frequently than binding to normal tissue, increases after 13-cis-RA treatment in vivo and is related to RA receptor beta expression. Cancer Res. 1995 Dec 1; 55(23):5507-11. PMID: 7585623.
        View in: PubMed
      387. Benner SE, Lippman S, Huber MH, Hong WK. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck. Semin Oncol. 1995 Oct; 22(5 Suppl 12):22-5. PMID: 7481857.
        View in: PubMed
      388. Ki Hong W, Lippman S, Hittelman WN, Lotan R. Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin Cancer Res. 1995 Jul; 1(7):677-86. PMID: 9816032.
        View in: PubMed
      389. Lee JS, Newman RA, Lippman S, Fossella FV, Calayag M, Raber MN, Krakoff IH, Hong WK. Phase I evaluation of all-trans retinoic acid with and without ketoconazole in adults with solid tumors. J Clin Oncol. 1995 Jun; 13(6):1501-8. PMID: 7751898.
        View in: PubMed
      390. Benner SE, Lippman S, Hong WK. Chemoprevention of lung cancer. Chest. 1995 Jun; 107(6 Suppl):316S-321S. PMID: 7781413.
        View in: PubMed
      391. Lotan R, Xu XC, Lippman S, Ro JY, Lee JS, Lee JJ, Hong WK. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med. 1995 May 25; 332(21):1405-10. PMID: 7723796.
        View in: PubMed
      392. Lippman S, Spitz MR, Huber MH, Hong WK. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck. Curr Opin Oncol. 1995 May; 7(3):234-41. PMID: 7654825.
        View in: PubMed
      393. Fossella FV, Lee JS, Shin DM, Calayag M, Huber M, Perez-Soler R, Murphy WK, Lippman S, Benner S, Glisson B. Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer. J Clin Oncol. 1995 Mar; 13(3):645-51. PMID: 7884425.
        View in: PubMed
      394. Hallum AV, Alberts DS, Lippman S, Inclan L, Shamdas GJ, Childers JM, Surwit EA, Modiano M, Hatch KD. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix. Gynecol Oncol. 1995 Mar; 56(3):382-6. PMID: 7705672.
        View in: PubMed
      395. Benner SE, Lippman S, Hong WK. Current status of retinoid chemoprevention of lung cancer. Oncology (Williston Park). 1995 Mar; 9(3):205-10; discussion 210, 213-4, 216. PMID: 7669514.
        View in: PubMed
      396. Gonzales-de Léon C, Lippman S, Kudelka AP, Edwards CL, Kavanagh JJ. Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervix. Invest New Drugs. 1995; 13(1):73-6. PMID: 7499112.
        View in: PubMed
      397. Huber MH, Lippman S, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK. Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer. Ann Oncol. 1995 Jan; 6(1):83-5. PMID: 7536031.
        View in: PubMed
      398. Lippman S, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, Hittelman WN, Hong WK. p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res. 1995 Jan 1; 55(1):16-9. PMID: 7805028.
        View in: PubMed
      399. Hays GL, Lippman S, Flaitz CM, Brown RS, Pang A, Devoll R, Hong WK. Co-carcinogenesis and field cancerization: oral lesions offer first signs. J Am Dent Assoc. 1995 Jan; 126(1):47-51. PMID: 7822645.
        View in: PubMed
      400. Clayman GL, Chamberlain RM, Lee JJ, Lippman S, Hong WK. Screening at a health fair to identify subjects for an oral leukoplakia chemoprevention trial. J Cancer Educ. 1995; 10(2):88-90. PMID: 7669540.
        View in: PubMed
      401. Lippman S, Clayman GL, Huber MH, Benner SE, Hong WK. Biology and reversal of aerodigestive tract carcinogenesis. Cancer Treat Res. 1995; 74:89-115. PMID: 7779624.
        View in: PubMed
      402. Lippman S, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem Suppl. 1995; 22:1-10. PMID: 8538183.
        View in: PubMed
      403. Hong WK, Lippman S. Cancer chemoprevention. J Natl Cancer Inst Monogr. 1995; (17):49-53. PMID: 8573453.
        View in: PubMed
      404. Benner SE, Pajak TF, Stetz J, Lippman S, Hong WK, Schantz SP, Gallagher MJ, Shenouda G. Toxicity of isotretinoin in a chemoprevention trial to prevent second primary tumors following head and neck cancer. J Natl Cancer Inst. 1994 Dec 7; 86(23):1799-801. PMID: 7966422.
        View in: PubMed
      405. Benner SE, Lippman S, Wargovich MJ, Lee JJ, Velasco M, Martin JW, Toth BB, Hong WK. Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy. Int J Cancer. 1994 Nov 15; 59(4):457-9. PMID: 7960211.
        View in: PubMed
      406. Lippman S, Spitz M, Trizna Z, Benner SE, Hong WK. Epidemiology, biology, and chemoprevention of aerodigestive cancer. Cancer. 1994 Nov 1; 74(9 Suppl):2719-25. PMID: 7954292.
        View in: PubMed
      407. Benner SE, Lippman S, Hong WK. Retinoid lung cancer prevention. Lung Cancer. 1994 Nov; 11 Suppl 3:S71-8. PMID: 7704516.
        View in: PubMed
      408. Benner SE, Lippman S, Hong WK. Retinoid chemoprevention of second primary tumors. Semin Hematol. 1994 Oct; 31(4 Suppl 5):26-30. PMID: 7831582.
        View in: PubMed
      409. Moore DM, Kalvakolanu DV, Lippman S, Kavanagh JJ, Hong WK, Borden EC, Paredes-Espinoza M, Krakoff IH. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin Hematol. 1994 Oct; 31(4 Suppl 5):31-7. PMID: 7831583.
        View in: PubMed
      410. Eisenhauer EA, Lippman S, Kavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, Massimini G, Schleuniger U, Bollag W, Holdener EE. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia. 1994 Oct; 8(10):1622-5. PMID: 7934156.
        View in: PubMed
      411. Fossella FV, Lee JS, Murphy WK, Lippman S, Calayag M, Pang A, Chasen M, Shin DM, Glisson B, Benner S. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Jun; 12(6):1238-44. PMID: 7911160.
        View in: PubMed
      412. Huber MH, Lippman S, Hong WK. Chemoprevention of head and neck cancer. Semin Oncol. 1994 Jun; 21(3):366-75. PMID: 8209268.
        View in: PubMed
      413. Lippman S, Donovan DT, Frankenthaler RA, Weber RS, Earley CL, Hong WK, Goepfert H. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. J Natl Cancer Inst. 1994 Jun 1; 86(11):859-61. PMID: 8182767.
        View in: PubMed
      414. Lippman S, Hong WK. 13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse. Ann Oncol. 1994 May; 5(5):391-3. PMID: 8075044.
        View in: PubMed
      415. Lee JS, Lippman S, Benner SE, Lee JJ, Ro JY, Lukeman JM, Morice RC, Peters EJ, Pang AC, Fritsche HA. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol. 1994 May; 12(5):937-45. PMID: 8164045.
        View in: PubMed
      416. Lippman S, Benner SE, Hong WK. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 1994 Apr 1; 54(7 Suppl):2025s-2028s. PMID: 8137332.
        View in: PubMed
      417. Lippman S, Benner SE, Hong WK. Cancer chemoprevention. J Clin Oncol. 1994 Apr; 12(4):851-73. PMID: 8151328.
        View in: PubMed
      418. Paredes Espinoza M, Lippman S, Kavanagh JJ, Delgadillo Madrueño F, Paredes Casillas P, Bañuelos Acosta O, Alvarez Márquez V, Buenrostro Ahued MA, de Alba Ayala I, Arias Castro G. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha]. Rev Invest Clin. 1994 Mar-Apr; 46(2):105-11. PMID: 8052740.
        View in: PubMed
      419. Benner SE, Pastorino U, Lippman S, Hong WK. Second international cancer chemoprevention conference. Cancer Res. 1994 Feb 1; 54(3):854-6. PMID: 7905788.
        View in: PubMed
      420. Benner SE, Pajak TF, Lippman S, Earley C, Hong WK. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl Cancer Inst. 1994 Jan 19; 86(2):140-1. PMID: 8271298.
        View in: PubMed
      421. Kurie JM, Lippman S, Hong WK. Potential of retinoids in cancer prevention. Cancer Treat Rev. 1994 Jan; 20(1):1-10. PMID: 8293427.
        View in: PubMed
      422. Benner SE, Wargovich MJ, Lippman S, Fisher R, Velasco M, Winn RJ, Hong WK. Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb; 3(1):73-6. PMID: 8118389.
        View in: PubMed
      423. Hong WK, Benner SE, Lippman S. Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience. Leukemia. 1994; 8 Suppl 3:S33-7. PMID: 7808022.
        View in: PubMed
      424. Eisenhauer EA, Lippman S, Kavanagh JJ, Parades-Espinoza M, Arnold A, Hong WK, Massimini G, Schleuniger U, Bollag W, Holdener EE. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Leukemia. 1994; 8 Suppl 3:S38-41. PMID: 7808023.
        View in: PubMed
      425. Huber MH, Shirinian M, Lippman S, Dimery IW, Frankenthaler RA, Hong WK. Phase I/II study of cisplatin, 5-fluorouracil and alpha-interferon for recurrent carcinoma of the head and neck. Invest New Drugs. 1994; 12(3):223-9. PMID: 7896541.
        View in: PubMed
      426. Benner SE, Lippman S, Hong WK. Chemoprevention of second primary tumours: a model for intervention trials. Eur J Cancer. 1994; 30A(6):727-9. PMID: 7917527.
        View in: PubMed
      427. Shirinian MH, Weber RS, Lippman S, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck. 1994 Jan-Feb; 16(1):39-44. PMID: 7510276.
        View in: PubMed
      428. Huber MH, Dimery IW, Benner SE, Lippman S, Shirinian M, Esparaz B, Frenning D, Guillory-Perez C, Hong WK. Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck. Invest New Drugs. 1994; 12(4):327-31. PMID: 7775135.
        View in: PubMed
      429. Lee JS, Kim SY, Hong WK, Lippman S, Ro JY, Gay ML, Hittelman WN. Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion. J Natl Cancer Inst. 1993 Dec 1; 85(23):1951-4. PMID: 8230287.
        View in: PubMed
      430. Hong WK, Lippman S, Wolf GT. Recent advances in head and neck cancer--larynx preservation and cancer chemoprevention: the Seventeenth Annual Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 1993 Nov 1; 53(21):5113-20. PMID: 8221647.
        View in: PubMed
      431. Lippman S, Benner SE, Hong WK. Retinoids in chemoprevention of head and neck carcinogenesis. Prev Med. 1993 Sep; 22(5):693-700. PMID: 8234209.
        View in: PubMed
      432. Lippman S, Benner SE, Hong WK. Chemoprevention. Strategies for the control of cancer. Cancer. 1993 Aug 1; 72(3 Suppl):984-90. PMID: 8334674.
        View in: PubMed
      433. Lippman S, Hong WK. Not yet standard: retinoids versus second primary tumors. J Clin Oncol. 1993 Jul; 11(7):1204-7. PMID: 8315418.
        View in: PubMed
      434. Toth BB, Martin JW, Lippman S, Hong WK. Chemoprevention as a form of cancer control. J Am Dent Assoc. 1993 Jul; 124(7):243-6. PMID: 8335795.
        View in: PubMed
      435. Kudelka AP, Freedman RS, Edwards CL, Lippman S, Tornos CS, Krakoff IH, Kavanagh JJ. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha. Anticancer Drugs. 1993 Jun; 4(3):335-7. PMID: 8358060.
        View in: PubMed
      436. Peters EJ, Morice R, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, Hong WK. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest. 1993 May; 103(5):1429-32. PMID: 8486022.
        View in: PubMed
      437. Lee JS, Newman RA, Lippman S, Huber MH, Minor T, Raber MN, Krakoff IH, Hong WK. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Oncol. 1993 May; 11(5):959-66. PMID: 8487058.
        View in: PubMed
      438. Lippman S, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Massimini G, Holdener EE, Krakoff IH. 13-cis-retinoic acid plus interferon-alpha 2a in locally advanced squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1993 Mar 17; 85(6):499-500. PMID: 8445678.
        View in: PubMed
      439. Voravud N, Lippman S, Weber RS, Rodriquez GI, Yee D, Dimery IW, Earley CL, Von Hoff DD, Hong WK. Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancer. Invest New Drugs. 1993 Feb; 11(1):57-60. PMID: 8349437.
        View in: PubMed
      440. Rinaldi DA, Lippman S, Burris HA, Chou C, Von Hoff DD, Hong WK. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer. Anticancer Drugs. 1993 Feb; 4(1):33-6. PMID: 8457712.
        View in: PubMed
      441. Dhingra K, Papadopoulos N, Lippman S, Lotan R, Legha SS. Phase II study of alpha-interferon and 13-cis-retinoic acid in metastatic melanoma. Invest New Drugs. 1993 Feb; 11(1):39-43. PMID: 8349434.
        View in: PubMed
      442. Munshi NC, Seitz DE, Fossella F, Lippman S, Einhorn LH. Phase II study of sulofenur (LY 186641). A novel antineoplastic agent in advanced non-small cell lung cancer. Invest New Drugs. 1993 Feb; 11(1):87-90. PMID: 8394298.
        View in: PubMed
      443. Vokes EE, Weichselbaum RR, Lippman S, Hong WK. Head and neck cancer. N Engl J Med. 1993 Jan 21; 328(3):184-94. PMID: 8417385.
        View in: PubMed
      444. Lippman S, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, Hong WK. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993 Jan 7; 328(1):15-20. PMID: 8416267.
        View in: PubMed
      445. Benner SE, Winn RJ, Lippman S, Poland J, Hansen KS, Luna MA, Hong WK. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst. 1993 Jan 6; 85(1):44-7. PMID: 8416256.
        View in: PubMed
      446. Benner SE, Wargovich MJ, Lippman S, Hong WK. Micronuclei: a potential intermediate marker for chemoprevention of aerodigestive tract cancer. J Cell Biochem Suppl. 1993; 17F:250-4. PMID: 8412201.
        View in: PubMed
      447. Lippman S, Benner SE, Hong WK. Chemoprevention strategies in lung carcinogenesis. Chest. 1993 Jan; 103(1 Suppl):15S-19S. PMID: 8416769.
        View in: PubMed
      448. Lippman S, Glisson BS, Kavanagh JJ, Lotan R, Hong WK, Paredes-Espinoza M, Hittelman WN, Holdener EE, Krakoff IH. Retinoic acid and interferon combination studies in human cancer. Eur J Cancer. 1993; 29A Suppl 5:S9-13. PMID: 8260265.
        View in: PubMed
      449. Heyne KH, Lippman S, Lee JJ, Lee JS, Hong WK. The incidence of second primary tumors in long-term survivors of small-cell lung cancer. J Clin Oncol. 1992 Oct; 10(10):1519-24. PMID: 1328547.
        View in: PubMed
      450. Benner SE, Lippman S, Wargovich MJ, Velasco M, Peters EJ, Morice RC, Hong WK. Micronuclei in bronchial biopsy specimens from heavy smokers: characterization of an intermediate marker of lung carcinogenesis. Int J Cancer. 1992 Aug 19; 52(1):44-7. PMID: 1500226.
        View in: PubMed
      451. Benner SE, Lippman S, Hong WK. Current status of chemoprevention of head and neck cancer. Oncology (Williston Park). 1992 Aug; 6(8):61-6; discussion 66-8, 71 passim. PMID: 1386997.
        View in: PubMed
      452. Schantz SP, Dimery I, Lippman S, Clayman GL, Pellegrino C, Morice R. A phase II study of interleukin-2 and interferon-alpha in head and neck cancer. Invest New Drugs. 1992 Aug; 10(3):217-23. PMID: 1428731.
        View in: PubMed
      453. Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman S, Shin DM, Dimery IW, Glisson BS, Hong WK. Improved therapeutic index by leucovorin of edatrexate, cyclophosphamide, and cisplatin regimen for non-small-cell lung cancer. J Natl Cancer Inst. 1992 Jul 1; 84(13):1039-40. PMID: 1318977.
        View in: PubMed
      454. Ihde DC, Lippman S. Intervention approaches in early lung cancer and premalignant disease: breakout group report. Cancer Res. 1992 May 1; 52(9 Suppl):2767s-2768s. PMID: 1563011.
        View in: PubMed
      455. Benner SE, Lippman S, Hong WK. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res. 1992 May 1; 52(9 Suppl):2758s-2763s. PMID: 1563008.
        View in: PubMed
      456. Lee JS, Lippman S, Hong WK, Ro JY, Kim SY, Lotan R, Hittelman WN. Determination of biomarkers for intermediate end points in chemoprevention trials. Cancer Res. 1992 May 1; 52(9 Suppl):2707s-2710s. PMID: 1348662.
        View in: PubMed
      457. Lippman S, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schusterman MA, Krakoff IH, Gutterman JU, Hong WK. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 1992 Feb 19; 84(4):235-41. PMID: 1734084.
        View in: PubMed
      458. Lippman S, Kavanagh JJ, Paredes-Espinoza M, Delgadillo-Madrueño F, Paredes-Casillas P, Hong WK, Holdener E, Krakoff IH. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst. 1992 Feb 19; 84(4):241-5. PMID: 1734085.
        View in: PubMed
      459. Lippman S, Bassford TL, Meyskens FL. A quantitatively scored cancer-risk assessment tool: its development and use. J Cancer Educ. 1992; 7(1):15-36. PMID: 1571244.
        View in: PubMed
      460. Benner SE, Hong WK, Lippman S, Lee JS, Hittelman WM. Intermediate biomarkers in upper aerodigestive tract and lung chemoprevention trials. J Cell Biochem Suppl. 1992; 16G:33-8. PMID: 1469903.
        View in: PubMed
      461. Lippman S, Hong WK. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis. Important Adv Oncol. 1992; 93-109. PMID: 1316312.
        View in: PubMed
      462. Lippman S, Hong WK. 13-cis-retinoic acid and cancer chemoprevention. J Natl Cancer Inst Monogr. 1992; (13):111-5. PMID: 1389684.
        View in: PubMed
      463. Lippman S, Hong WK. Chemoprevention of aerodigestive epithelial cancers. Adv Exp Med Biol. 1992; 320:151-61. PMID: 1442280.
        View in: PubMed
      464. Fossella FV, Lippman S, Seitz DE, Alberts DS, Taylor CW, Wiltshaw E, Hardy J, O'Brien M, Haynes TR, Wolen RL. Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases. Invest New Drugs. 1991 Nov; 9(4):357-9. PMID: 1804813.
        View in: PubMed
      465. Lee JS, Libshitz HI, Fossella FV, Murphy WK, Pang AC, Lippman S, Shin DM, Dimery IW, Glisson BS, Hong WK. Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer. Cancer. 1991 Sep 1; 68(5):959-64. PMID: 1655220.
        View in: PubMed
      466. Lippman S, Hong WK. Beta-carotene didn't prevent cancer: what's up doc? J Natl Cancer Inst. 1991 Aug 7; 83(15):1110-1. PMID: 1750915.
        View in: PubMed
      467. Heyne KE, Lippman S, Hong WK. Chemoprevention in head and neck cancer. Hematol Oncol Clin North Am. 1991 Aug; 5(4):783-95. PMID: 1890067.
        View in: PubMed
      468. Gordon PR, Bassford TL, Lippman S. Cancer risk reduction counseling: a computer-assisted curriculum. Am J Prev Med. 1991 Jul-Aug; 7(4):244-7. PMID: 1756062.
        View in: PubMed
      469. Lippman S, Hittelman WN, Lotan R, Pastorino U, Hong WK. Recent advances in cancer chemoprevention. Cancer Cells. 1991 Feb; 3(2):59-65. PMID: 1674206.
        View in: PubMed
      470. Rybski JA, Spier CM, Miller TP, Lippman S, McGee DL, Grogan TM. Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype. Leuk Lymphoma. 1991; 6(1):31-8. PMID: 27457573.
        View in: PubMed
      471. Hong WK, Lippman S, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20; 323(12):795-801. PMID: 2202902.
        View in: PubMed
      472. Modiano MR, Dalton WS, Lippman S, Joffe L, Booth AR, Meyskens FL. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest New Drugs. 1990 Aug; 8(3):317-9. PMID: 2148744.
        View in: PubMed
      473. Modiano MR, Dalton WS, Lippman S, Joffe L, Booth AR, Meyskens FL. Ocular toxic effects of fenretinide. J Natl Cancer Inst. 1990 Jun 20; 82(12):1063. PMID: 2140863.
        View in: PubMed
      474. Slymen DJ, Miller TP, Lippman S, Spier CM, Kerrigan DP, Rybski JA, Rangel CS, Richter LC, Grogan TM. Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J Clin Oncol. 1990 Jun; 8(6):986-93. PMID: 2140855.
        View in: PubMed
      475. Lippman S, Peters EJ, Wargovich MJ, Stadnyk AN, Dixon DO, Dekmezian RH, Loewy JW, Morice RC, Cunningham JE, Hong WK. Bronchial micronuclei as a marker of an early stage of carcinogenesis in the human tracheobronchial epithelium. Int J Cancer. 1990 May 15; 45(5):811-5. PMID: 2335384.
        View in: PubMed
      476. Lippman S, Spier CM, Miller TP, Slymen DJ, Rybski JA, Grogan TM. Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course. Mod Pathol. 1990 May; 3(3):361-7. PMID: 2194216.
        View in: PubMed
      477. Lippman S, Lee JS, Lotan R, Hittelman W, Wargovich MJ, Hong WK. Biomarkers as intermediate end points in chemoprevention trials. J Natl Cancer Inst. 1990 Apr 4; 82(7):555-60. PMID: 2179569.
        View in: PubMed
      478. Lippman S, Lee JS, Lotan R, Hong WK. Chemoprevention of upper aerodigestive tract cancers: a report of the third Upper Aerodigestive Cancer Task Force workshop. Head Neck. 1990 Jan-Feb; 12(1):5-20. PMID: 2404905.
        View in: PubMed
      479. Lippman S, Toth BB, Batsakis JG, Weber RS, McCarthy KS, Hays GL, Wargovich MJ, Lee JS, Thacher S, Lotan R. Modulation by 13-cis retinoic acid of biologic markers as indicators of intermediate endpoints in human oral carcinogenesis. Prog Clin Biol Res. 1990; 339:179-91. PMID: 1697415.
        View in: PubMed
      480. Weber RS, Lippman S, McNeese MD. Advanced basal and squamous cell carcinomas of the skin of the head and neck. Cancer Treat Res. 1990; 52:61-81. PMID: 1976376.
        View in: PubMed
      481. Lippman S, Peters EJ, Wargovich MJ, Dixon DO, Dekmezian RH, Cunningham JE, Loewy JW, Morice RC, Hong WK. The evaluation of micronuclei as an intermediate endpoint of bronchial carcinogenesis. Prog Clin Biol Res. 1990; 339:165-77. PMID: 1697414.
        View in: PubMed
      482. Lippman S, Garewal HS, Meyskens FL. Retinoids as potential chemopreventive agents in squamous cell carcinoma of the head and neck. Prev Med. 1989 Sep; 18(5):740-8. PMID: 2694167.
        View in: PubMed
      483. Lippman S, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989 Sep; 17(3):691-4. PMID: 2674081.
        View in: PubMed
      484. Lippman S, Meyskens FL. Results of the use of vitamin A and retinoids in cutaneous malignancies. Pharmacol Ther. 1989; 40(1):107-22. PMID: 2645584.
        View in: PubMed
      485. Spier CM, Grogan TM, Lippman S, Slymen DJ, Rybski JA, Miller TP. The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol. 1988 Oct; 133(1):118-26. PMID: 3140668.
        View in: PubMed
      486. Lippman S, Bassford TL, Meyskens FL. Quantitative assessment of cancer risk. Tex Med. 1988 Oct; 84(10):48-53. PMID: 3068823.
        View in: PubMed
      487. Lippman S, Shimm DS, Meyskens FL. Nonsurgical treatments for skin cancer: retinoids and alpha-interferon. J Dermatol Surg Oncol. 1988 Aug; 14(8):862-9. PMID: 3294268.
        View in: PubMed
      488. Lippman S, Meyskens FL. Vitamin A derivatives in the prevention and treatment of human cancer. J Am Coll Nutr. 1988 Aug; 7(4):269-84. PMID: 3062055.
        View in: PubMed
      489. Lippman S, Miller TP, Spier CM, Slymen DJ, Grogan TM. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood. 1988 Aug; 72(2):436-41. PMID: 3261181.
        View in: PubMed
      490. Miller TP, Lippman S, Spier CM, Slymen DJ, Grogan TM. HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. J Clin Invest. 1988 Jul; 82(1):370-2. PMID: 3392214.
        View in: PubMed
      491. Lippman S, Alberts DS, Slymen DJ, Weiner S, Aristizabal SA, Luditch A, Davis JR, Surwit EA. Second-look laparotomy in epithelial ovarian carcinoma. Prognostic factors associated with survival duration. Cancer. 1988 Jun 15; 61(12):2571-7. PMID: 3365677.
        View in: PubMed
      492. Grogan TM, Lippman S, Spier CM, Slymen DJ, Rybski JA, Rangel CS, Richter LC, Miller TP. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood. 1988 Apr; 71(4):1157-60. PMID: 3281723.
        View in: PubMed
      493. Lippman S, Kessler JF, Al-Sarraf M, Alberts DS, Itri LM, Mattox D, Von Hoff DD, Loescher L, Meyskens FL. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial. Invest New Drugs. 1988 Apr; 6(1):51-6. PMID: 3165972.
        View in: PubMed
      494. Spier CM, Lippman S, Miller TP, Grogan TM. Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival. Cancer. 1988 Feb 1; 61(3):517-24. PMID: 3257404.
        View in: PubMed
      495. Lippman S, Volk JR, Spier CM, Grogan TM. Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas. Arch Pathol Lab Med. 1988 Feb; 112(2):128-32. PMID: 3257381.
        View in: PubMed
      496. Lippman S, Meyskens FL. Retinoids as anticancer agents. Prog Clin Biol Res. 1988; 259:229-44. PMID: 3283747.
        View in: PubMed
      497. Lippman S, Lizak GE, Foung SK, Grumet FC. The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura. West J Med. 1988 Jan; 148(1):86-8. PMID: 3341139.
        View in: PubMed
      498. Lippman S, Meyskens FL. Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. Ann Intern Med. 1987 Oct; 107(4):499-502. PMID: 3477106.
        View in: PubMed
      499. Buzaid AC, Garewal HS, Lippman S, Durie BG, Katakkar SB, Greenberg BR. Danazol in the treatment of myelodysplastic syndromes. Eur J Haematol. 1987 Oct; 39(4):346-8. PMID: 3319676.
        View in: PubMed
      500. Buzaid AC, Lippman S, Miller TP. Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential. Am J Med. 1987 Sep; 83(3):523-32. PMID: 2444105.
        View in: PubMed
      501. Lippman S, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (Part II). Cancer Treat Rep. 1987 May; 71(5):493-515. PMID: 3552220.
        View in: PubMed
      502. Lippman S, Winn L, Grumet FC, Levitt LJ. Evans' syndrome as a presenting manifestation of atypical paroxysmal cold hemoglobinuria. Am J Med. 1987 May; 82(5):1065-72. PMID: 3578344.
        View in: PubMed
      503. Lippman S, Grogan TM, Carry P, Ogden DA, Miller TP. Post-transplantation T cell lymphoblastic lymphoma. Am J Med. 1987 Apr; 82(4):814-6. PMID: 3494399.
        View in: PubMed
      504. Lippman S, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents (Part I). Cancer Treat Rep. 1987 Apr; 71(4):391-405. PMID: 3548957.
        View in: PubMed
      505. Lippman S, Grogan TM, Spier CM, Koopmann CF, Gall EP, Shimm DS, Durie BG. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma. Cancer. 1987 Mar 1; 59(5):936-9. PMID: 3493060.
        View in: PubMed
      506. Fox KA, Lippman S, Cassady JR, Heusinkveld RS, Miller TP. Radiation therapy salvage of Hodgkin's disease following chemotherapy failure. J Clin Oncol. 1987 Jan; 5(1):38-45. PMID: 3806158.
        View in: PubMed
      507. Lippman S, Durie BG, Garewal HS, Giordano G, Greenberg BR. Efficacy of danazol in pure red cell aplasia. Am J Hematol. 1986 Dec; 23(4):373-9. PMID: 3098094.
        View in: PubMed
      508. Lippman S, Buzaid AC, Iacono RP, Steinbronn DV, Stanisic TH, Rennels MA, Yang PJ, Garewal HS, Ahmann FR. Cranial metastases from prostate cancer simulating meningioma: report of two cases and review of the literature. Neurosurgery. 1986 Nov; 19(5):820-3. PMID: 3785633.
        View in: PubMed
      509. Lippman S, Niemann JT, Thigpen T, Ginzton LE, Laks MM. Abnormal septal Q waves in sickle cell disease. Prevalence and causative factors. Chest. 1985 Oct; 88(4):543-8. PMID: 4042704.
        View in: PubMed
      510. Greenberg MR, Lippman S, Grinnell VS, Colman MF, Edwards JE. Computed tomographic findings in orbital Mucor. West J Med. 1985 Jul; 143(1):102-3. PMID: 4036105.
        View in: PubMed
      511. Lippman S, Abergel RP, Ginzton LE, Uitto J, Tanaka KR, Miyamoto EK, Laks MM. Mitral valve prolapse in sickle cell disease: manifestation of a generalized connective tissue disorder. Am J Hematol. 1985 May; 19(1):1-12. PMID: 3985003.
        View in: PubMed
      512. Lippman S, Ginzton LE, Thigpen T, Tanaka KR, Laks MM. Mitral valve prolapse in sickle cell disease. Presumptive evidence for a linked connective tissue disorder. Arch Intern Med. 1985 Mar; 145(3):435-8. PMID: 3977511.
        View in: PubMed
      513. Renie WA, Murphy RP, Anderson KC, Lippman S, McKusick VA, Proctor LR, Shimizu H, Patz A, Fine SL. The evaluation of patients with Eales' disease. Retina. 1983 Fall-Winter; 3(4):243-8. PMID: 6675099.
        View in: PubMed
      514. Lippman S, Arnett FC, Conley CL, Ness PM, Meyers DA, Bias WB. Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med. 1982 Dec; 73(6):827-40. PMID: 6756137.
        View in: PubMed
      515. Conley CL, Lippman S, Ness PM, Petz LD, Branch DR, Gallagher MT. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med. 1982 Feb 4; 306(5):281-6. PMID: 7054700.
        View in: PubMed
      516. Lippman S, Mendelsohn G, Trump DL, Wells SA, Baylin SB. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab. 1982 Feb; 54(2):233-40. PMID: 6798062.
        View in: PubMed
      517. Conley CL, Lippman S, Ness P. Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. JAMA. 1980 Oct 10; 244(15):1688-90. PMID: 7411826.
        View in: PubMed
      518. Cunningham JR, Lippman S, Renie WA, Francomano CA, Maumenee IH, Pyeritz RE. Pseudoxanthoma elasticum: treatment of gastrointestinal hemorrhage by arterial embolization and observations on autosomal dominant inheritance. Johns Hopkins Med J. 1980 Oct; 147(4):168-73. PMID: 6968373.
        View in: PubMed
      519. Geller J, Albert J, Nachtsheim D, Loza D, Lippman S. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy. Prog Clin Biol Res. 1979; 33:103-11. PMID: 93747.
        View in: PubMed
      520. Wall R, Lippman S, Toth K, Fedoroff N. A general method for the large-scale isolation of polysomes and messenger RNA applied to MOPC 21 mouse myeloma tumors. Anal Biochem. 1977 Sep; 82(1):115-29. PMID: 907116.
        View in: PubMed
      Scott's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _